Delaware |
7389 |
83-4629508 | ||
(State or other jurisdiction of incorporation or organization) |
(Primary Standard Industrial Classification Code Number) |
(I.R.S. Employer Identification No.) |
Christopher M. Forrester Shearman & Sterling LLP 1460 El Camino Real, Floor 2 Menlo Park, CA 94025 Tel: (650) 838-3600 |
Bryce Robinson Advantage Solutions Inc. 18100 Von Karman Avenue, Suite 1000 Irvine, CA 92612 Telephone: (949) 797-2900 |
Large accelerated filer | ☐ | ☒ | ||||
Non-accelerated filer |
☐ | Smaller reporting company | ||||
Emerging growth company |
| ||||||||
Title of Each Class of Securities to be Registered |
Amount to be Registered (1) |
Proposed Maximum Offering Price Per Share |
Proposed Maximum Aggregate Offering Price |
Amount of Registration Fee | ||||
Class A common stock, $0.0001 par value per share . |
35,057,319 (2) |
$10.01 (3) |
$350,923,763.19 | $38,285.78 | ||||
Class A common stock, $0.0001 par value per share, underlying warrants |
11,250,000 (4) |
$11.50 | $129,375,000 | $14,114.81 | ||||
Total |
$52,400.59 (5) | |||||||
| ||||||||
|
(1) | Pursuant to Rule 416(a), there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from share splits, share dividends or similar transactions. |
(2) | Consists of 35,057,319 shares of Class A common stock of the Registrant registered for sale by the selling stockholders named in this registration statement. |
(3) | Pursuant to Rule 457(c) under the Securities Act, and solely for the purpose of calculating the registration fee, the proposed maximum offering price per share is $10.01, which is the average of the high and low prices of the Class A common stock on November 18, 2020 on the Nasdaq Global Select Market. |
(4) | Consists of 11,250,000 shares of Class A common stock issuable by the Registrant upon the exercise of 11,250,000 issued and outstanding Warrants (as defined below). |
(5) | Previously paid. |
ii | ||||
iii | ||||
1 | ||||
4 | ||||
5 | ||||
32 | ||||
32 | ||||
33 | ||||
34 | ||||
68 | ||||
77 | ||||
87 | ||||
102 | ||||
108 | ||||
112 | ||||
115 | ||||
126 | ||||
128 | ||||
128 | ||||
128 | ||||
F-1 |
• | the COVID-19 pandemic and the measures taken to mitigate its spread including its adverse effects on our business, results of operations, financial condition and liquidity; |
• | developments with respect to retailers that are out of our control; |
• | changes to labor laws or wage or job classification regulations, including minimum wage, or other market-driven wage changes; |
• | our ability to continue to generate significant operating cash flow; |
• | consolidation within the industry of our clients creating pressure on the nature and pricing of our services; |
• | our reliance on continued access to retailers’ platforms; |
• | consumer goods manufacturers and retailers reviewing and changing their sales, retail, marketing, and technology programs and relationships; |
• | our ability to successfully develop and maintain relevant omni-channel services for our clients in an evolving industry and to otherwise adapt to significant technological change; |
• | client procurement strategies putting additional operational and financial pressure on our services; |
• | our ability to effectively remediate material weaknesses and maintain proper and effective internal controls in the future; |
• | potential and actual harms to our business arising from the matter related to the April 2018 acquisition of Take 5 Media Group (the “Take 5 Matter”); |
• | our ability to identify attractive acquisition targets, acquire them at attractive prices, and successfully integrate the acquired businesses; |
• | our ability to hire, timely train, and retain talented individuals for our workforce, and to maintain our corporate culture as we grow; |
• | our ability to avoid or manage business conflicts among competing brands; |
• | difficulties in integrating acquired businesses; |
• | our substantial indebtedness and our ability to refinance at favorable rates; |
• | limitations, restrictions, and business decisions involving our joint ventures and minority investments; |
• | exposure to foreign currency exchange rate fluctuations and risks related to our international operations; |
• | the ability to maintain applicable listing standards; |
• | the ability to recognize the anticipated benefits of the Transactions, which may be affected by, among other things, competition, our ability to grow and manage growth profitably, maintain relationships with customers and suppliers and retain our management and key employees; |
• | changes in applicable laws or regulations; |
• | the possibility that we may be adversely affected by other political, economic, business, and/or competitive factors; |
• | other factors disclosed in this prospectus; and |
• | other factors beyond our control. |
Issuer |
Advantage Solutions Inc. (f/k/a Conyers Park II Acquisition Corp.). |
Shares of Class A Common Stock Offered by us |
11,250,000 shares of Class A common stock issuable upon exercise of the Warrants. |
Shares of Class A Common Stock Outstanding Prior to Exercise of All Warrants |
318,449,966 shares (as of May 17, 2021). |
Shares of Class A Common Stock Outstanding Assuming Exercise of All Warrants |
329,699,966 shares (based on total shares outstanding as of May 17, 2021). |
Exercise Price of Warrants |
$11.50 per share, subject to adjustment as described herein. |
Use of Proceeds |
We will receive up to an aggregate of approximately $129.4 million from the exercise of the Warrants, assuming the exercise in full of all of the Warrants for cash. We expect to use the net proceeds from the exercise of the Warrants for general corporate purposes. See “ Use of Proceeds. |
Shares of Class A Common Stock Offered by the Selling Stockholders |
35,057,319 shares. |
Use of Proceeds |
We will not receive any proceeds from the sale of shares of Class A common stock by the Selling Stockholders. |
Market for Class A common stock and Warrants |
Our Class A common stock and Warrants are currently traded on the Nasdaq Global Select Market under the symbols “ADV” and “ADVWW,” respectively. |
Risk Factors |
See “ Risk Factors |
• | the COVID-19 pandemic and the measures taken to mitigate its spread including its adverse effects on our business, results of operations, financial condition and liquidity; |
• | developments with respect to retailers that are out of our control; |
• | changes to labor laws or wage or job classification regulations, including minimum wage, or other market-driven wage changes; |
• | our ability to continue to generate significant operating cash flow; |
• | consolidation within the industry of our clients creating pressure on the nature and pricing of our services; |
• | our reliance on continued access to retailers’ platforms; |
• | consumer goods manufacturers and retailers reviewing and changing their sales, retail, marketing, and technology programs and relationships; |
• | our ability to successfully develop and maintain relevant omni-channel services for our clients in an evolving industry and to otherwise adapt to significant technological change; |
• | client procurement strategies putting additional operational and financial pressure on our services; |
• | our ability to effectively remediate material weaknesses and maintain proper and effective internal controls in the future; |
• | potential and actual harms to our business arising from the matter related to the April 2018 acquisition of Take 5 Media Group (the “Take 5 Matter”); |
• | our ability to identify attractive acquisition targets, acquire them at attractive prices, and successfully integrate the acquired businesses; |
• | our ability to hire, timely train, and retain talented individuals for our workforce, and to maintain our corporate culture as we grow; |
• | our ability to avoid or manage business conflicts among competing brands; |
• | difficulties in integrating acquired businesses; |
• | our substantial indebtedness and our ability to refinance at favorable rates; |
• | limitations, restrictions, and business decisions involving our joint ventures and minority investments; |
• | exposure to foreign currency exchange rate fluctuations and risks related to our international operations; |
• | the ability to maintain applicable listing standards; |
• | the ability to recognize the anticipated benefits of the Transactions, which may be affected by, among other things, competition, our ability to grow and manage growth profitably, maintain relationships with customers and suppliers and retain our management and key employees; |
• | changes in applicable laws or regulations; and |
• | the possibility that we may be adversely affected by other political, economic, business, and/or competitive factors. |
• | potential changes in the policies of retailers in response to the COVID-19 pandemic, including changes to or restrictions on their outsourcing of sales and marketing functions and restrictions on the performance of in-store demonstration services, if permitted at all; |
• | potential changes in the demand for services by our clients in response to the COVID-19 pandemic; |
• | the need for us to adapt to technological change and otherwise develop and maintain omni-channel solutions; |
• | our ability to generate sufficient cash to service our substantial indebtedness; |
• | our ability to maintain our credit rating; |
• | our ability to offer high-quality customer support and maintain our reputation; |
• | our ability to identify, perform adequate diligence on and consummate acquisitions of attractive business targets, and then subsequently integrate such acquired businesses; |
• | our ability to hire, timely train and retain talented individuals for our workforce; |
• | our ability to maintain our corporate culture; |
• | severe disruption and instability in the U.S. and global financial markets or deteriorations in credit and financing conditions, which could make it difficult for us to access debt and equity capital on attractive terms, or at all; |
• | our ability to effectively manage our operations while a significant amount of our associates continue to work remotely due to the COVID-19 pandemic; |
• | deteriorating economic conditions, higher unemployment, public transportation disruptions or other disruptions as a result of the COVID-19 pandemic which could result in lower-than-planned sales during key revenue-producing seasons, leading to lower revenues; |
• | potential cost-saving strategies implemented by clients that reduce fees paid to third-party service providers such as ourselves; and |
• | our ability to implement additional internal control measures to improve our internal control over financial reporting. |
• | We determined that we did not design and maintain effective controls related to our due diligence procedures for potential acquisitions with respect to databases and information technology systems used to recognize revenue and determine the satisfaction of performance obligations. Specifically, internal controls were not designed and maintained to assess the risks associated with potential acquisitions and the need to perform due diligence as part of purchase accounting with respect to databases and information technology systems utilized to determine the satisfaction of performance obligations, and to communicate and evaluate the results of due diligence. |
• | We determined that we did not design and maintain effective controls to establish an appropriate basis for reliance on data and information in our information technology systems used for revenue recognition in certain of our newly acquired businesses. Specifically, internal controls were not designed and maintained to ensure the completeness and accuracy of system generated reports used to verify the satisfaction of performance obligations. |
• | We determined that we did not design and maintain effective controls related to information and communication specifically with respect to our whistleblower complaint process to properly investigate, communicate and resolve whistleblower complaints and allegations related to accounting |
or other misconduct in a timely manner, and with respect to communication with appropriate parties. Specifically, internal controls were not designed and maintained to ensure that individuals conducting investigations into allegations of accounting or other misconduct had the appropriate expertise and supervision, and that the results of the investigations have been communicated to the appropriate parties or that other transactions are communicated to the appropriate parties. |
• | In order to validate more fully an acquisition target with databases and information technology systems used to recognize revenue and determine the satisfaction of performance obligations, we are designing and implementing policies and procedures to perform more robust risk assessment and due diligence procedures in connection with such potential acquisitions, including engaging third-party experts to evaluate such target companies’ databases or information technology, and enhancing the communication and evaluation of due diligence results, as appropriate. |
• | We are enhancing our procedures related to the risk assessment, evaluation of the completeness and accuracy of our internal reporting processes with respect to newly acquired businesses, including with respect to the completeness and accuracy of reports used to verify the satisfaction of performance obligations under client contracts and the accuracy of recognized revenues. |
• | We are designing, enhancing and implementing procedures and policies to promote timely and proper risk assessment, investigation, resolution, communication and disclosure of any whistleblower complaints or reported allegations of accounting or other misconduct. |
• | In addition, we are designing and implementing various controls, including additional policies, procedures and training, to enhance our disclosure committee process and communication of pertinent information to the appropriate parties in connection with the issuance or reissuance of our consolidated financial statements. |
• | We plan to design and implement a control activity to evaluate the settlement features used to determine the classification of certain warrant instruments. Specifically, this will include the evaluation and research of the complex accounting standards that apply to these instruments. |
• | the diversion of management attention to integration matters; |
• | difficulties in integrating functional roles, processes and systems, including accounting systems; |
• | challenges in conforming standards, controls, procedures and accounting and other policies, business cultures and compensation structures between the two companies; |
• | difficulties in assimilating, attracting and retaining key personnel; |
• | challenges in keeping existing clients and obtaining new clients; |
• | difficulties in achieving anticipated cost savings, synergies, business opportunities and growth prospects from the Transactions; |
• | difficulties in managing the expanded operations of a significantly larger and more complex business; |
• | contingent liabilities, including contingent tax liabilities or litigation, that may be larger than expected; and |
• | potential unknown liabilities, adverse consequences or unforeseen increased expenses associated with an acquisition, including possible adverse tax consequences to the combined business pursuant to changes in applicable tax laws or regulations. |
• | costs of customizing services for clients outside of the United States; |
• | the burdens of complying with a wide variety of foreign laws; |
• | potential difficulty in enforcing contracts; |
• | being subject to U.S. laws and regulations governing international operations, including the U.S. |
• | Foreign Corrupt Practices Act and sanctions regimes; |
• | being subject to foreign anti-bribery laws in the jurisdictions in which we operate, such as the UK Bribery Act; |
• | reduced protection for intellectual property rights; |
• | increased financial accounting and reporting complexity; |
• | exposure to foreign currency exchange rate fluctuations; |
• | exposure to local economic conditions; |
• | limitations on the repatriation of funds or profits from foreign operations; |
• | exposure to local political conditions, including adverse tax policies and civil unrest; |
• | the risks of a natural disaster, public health crisis (including the occurrence of a contagious disease or illness, such as the coronavirus), an outbreak of war, the escalation of hostilities and acts of terrorism in the jurisdictions in which we operate; and |
• | the disparate impact of the COVID-19 pandemic, including the measures taken to mitigate its spread, across various jurisdictions. |
• | changes in the valuation of our deferred tax assets and liabilities; |
• | expected timing and amount of the release of any tax valuation allowance; |
• | tax effects of equity-based compensation; |
• | changes in tax laws, regulations or interpretations thereof; or |
• | future earnings being lower than anticipated in jurisdictions where we have lower statutory tax rates and higher than anticipated earnings in jurisdictions where we have higher statutory tax rates. |
• | authorizing the issuance of “blank check” preferred stock that could be issued by our board of directors to increase the number of outstanding shares and thwart a takeover attempt; |
• | provision for a classified board of directors so that not all members of our board of directors are elected at one time; |
• | not permitting the use of cumulative voting for the election of directors; |
• | permitting the removal of directors only for cause; |
• | limiting the ability of stockholders to call special meetings; |
• | requiring all stockholder actions to be taken at a meeting of our stockholders; |
• | requiring approval of the holders of at least two-thirds of the shares entitled to vote at an election of directors to adopt, amend, or repeal the proposed bylaws or repeal the provisions of the second amended and restated certificate of incorporation regarding the election and removal of directors; and |
• | establishing advance notice requirements for nominations for election to the board of directors or for proposing matters that can be acted upon by stockholders at stockholder meetings. |
• | quarterly variations in our operating results compared to market expectations; |
• | changes in preferences of our clients; |
• | announcements of new products or services or significant price reductions; |
• | the size of our public float; |
• | fluctuations in stock market prices and volumes; |
• | defaults on our indebtedness; |
• | changes in senior management or key personnel; |
• | the granting, vesting, or exercise of employee stock options, restricted stock, or other equity rights; |
• | the payment of any dividends thereon in shares of our common stock; |
• | changes in financial estimates or recommendations by securities analysts; |
• | negative earnings or other announcements by us; |
• | downgrades in our credit ratings; |
• | material litigation or governmental investigations; |
• | issuances of capital stock; |
• | global economic, legal, and regulatory factors unrelated to our performance, including the COVID-19 pandemic; or |
• | the realization of any risks described in this prospectus under “Risk Factors.” |
• | you may not be able to liquidate your investment in shares of Class A common stock; |
• | you may not be able to resell your shares of Class A common stock at or above the price attributed to them in the Transactions; |
• | the market price of shares of Class A common stock may experience significant price volatility; and |
• | there may be less efficiency in carrying out your purchase and sale orders. |
• | our sales segment revenues, operating income, and Adjusted EBITDA increased 5.2%, 45.3%, and 7.0%, respectively, and; |
• | our market segment revenues, operating income and Adjusted EBITDA decreased 30.9%, 66.3% and 1.6%, respectively. |
• | our sales segment revenues increased 5.4% and its operating income and Adjusted EBITDA decreased 50.5% and increased 16.3% and; |
• | our market segment revenues, operating income and Adjusted EBITDA decreased 40.2%, 95.7% and 34.6%, respectively. |
• | revenues decreasing by $88.4 million, or 10.0%, to $791.0 million; |
• | operating income increasing by $6.2 million, or 19.6%, to $37.6 million; |
• | net loss decreasing by $21.2 million, or 97.5%, to $0.5 million; |
• | Adjusted Net Income increasing by $19.4 million, or 72.3%, to $46.3 million; and |
• | Adjusted EBITDA increasing by $5.1 million, or 4.8%, to $111.4 million. |
• | Revenues decreased by $629.4 million, or 16.6%, to $3,155.7 million; |
• | Operating income decreased by $146.7 million, or 68.6%, to $67.0 million; |
• | Net loss increased by $155.3 million, or 786.2%, to $175.1 million; |
• | Adjusted Net Income increased by $13.9 million, or 8.2%, to $182.9 million; and |
• | Adjusted EBITDA decreased by $16.9 million, or 3.3%, to $487.2 million. |
• | Organic Growth. |
• | Acquisitions. strategic and tuck-in acquisitions that can be completed at attractive purchase prices. |
• | Contingent Consideration. |
• | Depreciation and Amortization. we must re-invest in property and equipment to maintain the asset base delivering our results of operations, we do not have any capital re-investment requirements associated with the acquired intangibles, such as client relationships and trade names, that comprise the majority of the finite-lived intangibles that create our amortization expense. |
• | Foreign Exchange Fluctuations. —Quantitative and Qualitative Disclosure of Market Risk—Foreign Currency Risk. |
• | Seasonality. |
Three Months Ended March 31, |
||||||||||||||||
(amounts in thousands) |
2021 |
2020 |
||||||||||||||
Revenues |
$ | 791,021 | 100.0 | % | $ | 879,396 | 100.0 | % | ||||||||
Cost of revenues |
653,339 | 82.6 | % | 746,693 | 84.9 | % | ||||||||||
Selling, general, and administrative expenses |
40,481 | 5.1 | % | 41,056 | 4.7 | % | ||||||||||
Depreciation and amortization |
59,613 | 7.5 | % | 60,209 | 6.8 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total expenses |
753,433 | 95.2 | % | 847,958 | 96.4 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating income |
37,588 | 4.8 | % | 31,438 | 3.6 | % | ||||||||||
Other expenses: |
||||||||||||||||
Change in fair value of warrant liability |
5,526 | 0.7 | % | — | 0.0 | % | ||||||||||
Interest expense, net |
30,865 | 3.9 | % | 51,794 | 5.9 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total other expenses |
36,391 | 4.6 | % | 51,794 | 5.9 | % | ||||||||||
Loss before income taxes |
1,197 | 0.2 | % | (20,356 | ) | (2.3 | )% | |||||||||
Provision for income taxes |
1,743 | 0.2 | % | 1,367 | 0.2 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net loss |
$ | (546 | ) | (0.1 | )% | $ | (21,723 | ) | (2.5 | )% | ||||||
|
|
|
|
|
|
|
|
|||||||||
Other Financial Data |
||||||||||||||||
Adjusted Net Income (1) |
$ | 46,264 | 5.8 | % | $ | 26,849 | 3.1 | % | ||||||||
Adjusted EBITDA (1) |
$ | 111,428 | 14.1 | % | $ | 106,351 | 12.1 | % |
(1) | Adjusted Net Income and Adjusted EBITDA is a financial measure that is not calculated in accordance with GAAP. For a discussion of our presentation of Adjusted Net Income and Adjusted EBITDA and reconciliations of net loss to Adjusted Net Income and Adjusted EBITDA, see “ —Non-GAAP Financial Measures. |
Three Months Ended March 31, |
Change |
|||||||||||||||
(amounts in thousands) |
2021 |
2020 |
$ |
% |
||||||||||||
Sales |
$ | 534,324 | $ | 507,798 | $ | 26,526 | 5.2 | % | ||||||||
Marketing |
256,697 | 371,598 | (114,901 | ) | (30.9 | )% | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total revenues |
$ | 791,021 | $ | 879,396 | $ | (88,375 | ) | (10.0 | )% | |||||||
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
Change |
|||||||||||||||
(amounts in thousands) |
2021 |
2020 |
$ |
% |
||||||||||||
Sales |
$ | 35,148 | $ | 24,194 | $ | 10,954 | 45.3 | % | ||||||||
Marketing |
2,440 | 7,244 | (4,804 | ) | (66.3 | )% | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total operating income |
$ | 37,588 | $ | 31,438 | $ | 6,150 | 19.6 | % | ||||||||
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
Change |
|||||||||||||||
(amounts in thousands) |
2021 |
2020 |
$ |
% |
||||||||||||
Sales |
$ | 84,076 | $ | 78,563 | $ | 5,513 | 7.0 | % | ||||||||
Marketing |
27,352 | 27,788 | (436 | ) | (1.6 | )% | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total Adjusted EBITDA |
$ | 111,428 | $ | 106,351 | $ | 5,077 | 4.8 | % | ||||||||
|
|
|
|
|
|
|
|
Year Ended December 31, |
||||||||||||||||
(amounts in thousands) |
2020 |
2019 |
||||||||||||||
Revenues |
$ | 3,155,671 | 100.0 | % | $ | 3,785,063 | 100.0 | % | ||||||||
Cost of revenues |
2,551,485 | 80.9 | % | 3,163,443 | 83.6 | % | ||||||||||
Selling, general, and administrative expenses |
306,282 | 9.7 | % | 175,373 | 4.6 | % | ||||||||||
Recovery from Take 5 |
(7,700 | ) | (0.2 | )% | — | 0.0 | % | |||||||||
Depreciation and amortization |
238,598 | 7.6 | % | 232,573 | 6.1 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total expenses |
3,088,665 | 97.9 | % | 3,571,389 | 94.4 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating income |
67,006 | 2.1 | % | 213,674 | 5.6 | % | ||||||||||
Other expenses: |
||||||||||||||||
Change in fair value of warrant liability |
13,363 | 0.4 | % | — | 0.0 | % | ||||||||||
Interest expense, net |
234,044 | 7.4 | % | 232,077 | 6.1 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total other expenses |
247,407 | 7.8 | % | 232,077 | 6.1 | % | ||||||||||
Loss before income taxes |
(180,401 | ) | (5.7 | )% | (18,403 | ) | (0.5 | )% | ||||||||
(Benefit from) provision for income taxes |
(5,331 | ) | (0.2 | )% | 1,353 | 0.0 | % | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Net loss |
$ | (175,070 | ) | (5.5 | )% | $ | (19,756 | ) | (0.5 | )% | ||||||
|
|
|
|
|
|
|
|
|||||||||
Other Financial Data |
||||||||||||||||
Adjusted Net Income (1) |
$ | 182,969 | 5.8 | % | $ | 169,109 | 4.5 | % | ||||||||
Adjusted EBITDA (1) |
$ | 487,175 | 15.4 | % | $ | 504,031 | 13.3 | % |
(1) | Adjusted Net Income and Adjusted EBITDA are financial measures that are not calculated in accordance with GAAP. For a discussion of our presentation of Adjusted Net Income and Adjusted EBITDA and reconciliations of net loss to Adjusted Net Income and Adjusted EBITDA, see “ —Non-GAAP Financial Measures. |
Year Ended December 31, |
Change |
|||||||||||||||
(amounts in thousands) |
2020 |
2019 |
$ |
% |
||||||||||||
Sales |
$ | 2,060,593 | $ | 1,954,705 | $ | 105,888 | 5.4 | % | ||||||||
Marketing |
1,095,078 | 1,830,358 | (735,280 | ) | (40.2 | )% | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total revenues |
$ | 3,155,671 | $ | 3,785,063 | $ | (629,392 | ) | (16.6 | )% | |||||||
|
|
|
|
|
|
|
|
Year Ended December 31, |
Change |
|||||||||||||||
(amounts in thousands) |
2020 |
2019 |
$ |
% |
||||||||||||
Sales |
$ | 63,305 | $ | 127,961 | $ | (64,656 | ) | (50.5 | )% | |||||||
Marketing |
3,701 | 85,713 | (82,012 | ) | (95.7 | )% | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total operating income |
$ | 67,006 | $ | 213,674 | $ | (146,668 | ) | (68.6 | )% | |||||||
|
|
|
|
|
|
|
|
Year Ended December 31, |
Change |
|||||||||||||||
(amounts in thousands) |
2020 |
2019 |
$ |
% |
||||||||||||
Sales |
$ | 360,017 | $ | 309,531 | $ | 50,486 | 16.3 | % | ||||||||
Marketing |
127,158 | 194,500 | (67,342 | ) | (34.6 | )% | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total Adjusted EBITDA |
$ | 487,175 | $ | 504,031 | $ | (16,856 | ) | (3.3 | )% | |||||||
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
Year Ended December 31, |
|||||||||||||||||||
(in thousands) |
2021 |
2020 |
2020 |
2019 |
2018 |
|||||||||||||||
Net loss |
$ | (546 | ) | $ | (21,723 | ) | $ | (175,070 | ) | $ | (19,756 | ) | $ | (1,151,223 | ) | |||||
Less: Net (loss) income attributable to noncontrolling interest |
(430 | ) | (15 | ) | 736 | 1,416 | 6,109 | |||||||||||||
Add: |
||||||||||||||||||||
Impairment of goodwill and indefinite-lived assets |
— | — | — | — | 1,232,000 | |||||||||||||||
Equity based compensation of Topco and Advantage Sponsors’ management fee (a) |
(2,814 | ) | 3,837 | 98,119 | 7,960 | (2,432 | ) | |||||||||||||
Change in fair value of warrant liability |
5,526 | — | 13,363 | — | — | |||||||||||||||
Fair value adjustments related to contingent consideration related to acquisitions (c) |
(1,043 | ) | 4,095 | 13,367 | 1,516 | (54,464 | ) | |||||||||||||
Acquisition-related expenses (d) |
5,146 | 5,529 | 50,823 | 31,476 | 61,155 | |||||||||||||||
Restructuring expenses (e) |
4,096 | 1,098 | 39,770 | 5,385 | 12,465 | |||||||||||||||
Litigation expenses (f) |
(818 | ) | 104 | 1,980 | 3,500 | 1,200 | ||||||||||||||
Amortization of intangible assets (g) |
49,438 | 47,846 | 193,543 | 189,881 | 188,831 | |||||||||||||||
Costs associated with COVID-19, net of benefits received(h) |
1,293 | 1,000 | (11,954 | ) | — | — | ||||||||||||||
Deferred financing fees (i) |
— | — | 41,428 | — | — | |||||||||||||||
(Recovery from) loss on Take 5 |
— | — | (7,700 | ) | — | 79,165 | ||||||||||||||
Costs associated with the Take 5 Matter (j) |
901 | 939 | 3,628 | 16,368 | 14,178 | |||||||||||||||
Tax adjustments related to non-GAAP adjustments(k) |
(15,345 | ) | (15,891 | ) | (77,592 | ) | (65,805 | ) | (238,615 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Adjusted Net Income |
$ | 46,264 | $ | 26,849 | $ | 182,969 | $ | 169,109 | $ | 136,151 | ||||||||||
|
|
|
|
|
|
|
|
|
|
Consolidated |
Three Months Ended March 31, |
Year Ended December 31, |
||||||||||||||||||
(in thousands) |
2021 |
2020 |
2020 |
2019 |
2018 |
|||||||||||||||
Net loss |
$ | (546 | ) | $ | (21,723 | ) | $ | (175,070 | ) | $ | (19,756 | ) | $ | (1,151,223 | ) | |||||
Add: |
||||||||||||||||||||
Interest expense, net |
30,865 | 51,794 | 234,044 | 232,077 | 229,643 | |||||||||||||||
Provision for income taxes |
1,743 | 1,367 | (5,331 | ) | 1,353 | (168,334 | ) | |||||||||||||
Depreciation and amortization |
59,613 | 60,209 | 238,598 | 232,573 | 225,233 | |||||||||||||||
Impairment of goodwill and indefinite-lived assets |
— | — | — | — | 1,232,000 | |||||||||||||||
Equity based compensation of Topco and Advantage Sponsors’ management fee (a) |
(2,814 | ) | 3,837 | 98,119 | 7,960 | (2,432 | ) | |||||||||||||
Change in fair value of warrant liability |
5,526 | — | 13,363 | — | — | |||||||||||||||
Stock based compensation expense (b) |
8,655 | — | — | — | — | |||||||||||||||
Fair value adjustments related to contingent consideration related to acquisitions (c) |
(1,043 | ) | 4,095 | 13,367 | 1,516 | (54,464 | ) | |||||||||||||
Acquisition-related expenses (d) |
5,146 | 5,529 | 50,823 | 31,476 | 61,155 | |||||||||||||||
EBITDA for economic interests in investments (l) |
(1,189 | ) | (1,898 | ) | (6,462 | ) | (8,421 | ) | (7,212 | ) | ||||||||||
Restructuring expenses (e) |
4,096 | 1,098 | 39,770 | 5,385 | 12,465 | |||||||||||||||
Litigation expenses (f) |
(818 | ) | 104 | 1,980 | 3,500 | 1,200 | ||||||||||||||
Costs associated with COVID-19, net of benefits received(h) |
1,293 | 1,000 | (11,954 | ) | — | — | ||||||||||||||
(Recovery from) loss on Take 5 |
— | — | (7,700 | ) | — | 79,165 | ||||||||||||||
Costs associated with the Take 5 Matter (j) |
901 | 939 | 3,628 | 16,368 | 14,178 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Adjusted EBITDA |
$ | 111,428 | $ | 106,351 | $ | 487,175 | $ | 504,031 | $ | 471,374 | ||||||||||
|
|
|
|
|
|
|
|
|
|
Sales Segment |
Three Months Ended March 31, |
Year Ended December 31, |
||||||||||||||||||
(in thousands) |
2021 |
2020 |
2020 |
2019 |
2018 |
|||||||||||||||
Operating income (loss) |
$ | 35,148 | $ | 24,194 | $ | 63,305 | $ | 127,961 | $ | (1,072,702 | ) | |||||||||
Add: |
||||||||||||||||||||
Depreciation and amortization |
42,564 | 43,107 | 171,569 | 161,563 | 157,098 | |||||||||||||||
Impairment of goodwill and indefinite-lived assets |
— | — | — | — | 1,232,000 | |||||||||||||||
Equity based compensation of Topco and Advantage Sponsors’ management fee (a) |
(1,838 | ) | 3,199 | 71,124 | 6,418 | 1,020 | ||||||||||||||
Stock based compensation expense (b) |
4,694 | — | — | — | — | |||||||||||||||
Fair value adjustments related to contingent consideration related to acquisitions (c) |
778 | 4,312 | 8,371 | (2,720 | ) | (54,628 | ) | |||||||||||||
Acquisition-related expenses (d) |
3,320 | 4,156 | 36,722 | 18,276 | 31,699 | |||||||||||||||
EBITDA for economic interests in investments (l) |
(1,487 | ) | (2,071 | ) | (7,565 | ) | (8,395 | ) | (7,155 | ) | ||||||||||
Restructuring expenses (e) |
780 | 752 | 20,295 | 2,928 | 6,663 | |||||||||||||||
Litigation expenses (f) |
(516 | ) | 104 | 1,658 | 3,500 | 1,200 | ||||||||||||||
Costs associated with COVID-19, net of benefits received(h) |
633 | 810 | (5,462 | ) | — | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Sales Segment Adjusted EBITDA |
$ | 84,076 | $ | 78,563 | $ | 360,017 | $ | 309,531 | $ | 295,195 | ||||||||||
|
|
|
|
|
|
|
|
|
|
Marketing Segment |
Three Months Ended March 31, |
Year Ended December 31, |
||||||||||||||||||
(in thousands) |
2021 |
2020 |
2020 |
2019 |
2018 |
|||||||||||||||
Operating income (loss) |
$ | 2,440 | $ | 7,244 | $ | 3,701 | $ | 85,713 | $ | (17,212 | ) | |||||||||
Add: |
||||||||||||||||||||
Depreciation and amortization |
17,049 | 17,102 | 67,029 | 71,010 | 68,135 | |||||||||||||||
Equity based compensation of Topco and Advantage Sponsors’ management fee (a) |
(976 | ) | 638 | 26,995 | 1,542 | (3,452 | ) | |||||||||||||
Stock based compensation expense (b) |
3,961 | — | — | — | — | |||||||||||||||
Fair value adjustments related to contingent consideration related to acquisitions (c) |
(1,821 | ) | (217 | ) | 4,996 | 4,236 | 164 | |||||||||||||
Acquisition-related expenses (d) |
1,826 | 1,373 | 14,101 | 13,200 | 29,456 | |||||||||||||||
EBITDA for economic interests in investments (l) |
298 | 173 | 1,103 | (26 | ) | (57 | ) | |||||||||||||
Restructuring expenses (e) |
3,316 | 346 | 19,475 | 2,457 | 5,802 | |||||||||||||||
Litigation expenses (f) |
(302 | ) | — | 322 | — | — | ||||||||||||||
Costs associated with COVID-19, net of benefits received(h) |
660 | 190 | (6,492 | ) | — | — | ||||||||||||||
(Recovery from) loss on Take 5 |
— | — | (7,700 | ) | — | 79,165 | ||||||||||||||
Costs associated with the Take 5 Matter (j) |
901 | 939 | 3,628 | 16,368 | 14,178 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Marketing Segment Adjusted EBITDA |
$ | 27,352 | $ | 27,788 | $ | 127,158 | $ | 194,500 | $ | 176,179 | ||||||||||
|
|
|
|
|
|
|
|
|
|
(a) | Represents the management fees and reimbursements for expenses paid to certain of the Advantage Sponsors (or certain of the management companies associated with it or its advisors) pursuant to a management services agreement in the three months ended March 31, 2021 and 2020. Also represents expenses related to (i) equity-based compensation expense associated with grants of Common Series D Units of Topco made to one of the Advantage Sponsors, (ii) equity-based compensation expense associated with the Common Series C Units of Topco as a result of the Transactions, (iii) compensation amounts associated with the Company’s Management Incentive Plan originally scheduled for potential payment |
March 2022 that were accelerated and terminated as part of the Transactions, and (iv) compensation amounts associated with the anniversary payments to Tanya Domier. Certain of Ms. Domier’s anniversary payments were accelerated as part of the Transactions. |
(b) | Represents non-cash compensation expense related to issuance of PSUs, RSUs and stock options under the 2020 Plan. |
(c) | Represents adjustments to the estimated fair value of our contingent consideration liabilities related to our acquisitions, excluding the present value accretion recorded in interest expense, net, for the applicable periods. See Note 6— Fair Value of Financial Instruments |
(d) | Represents fees and costs associated with activities related to our acquisitions and restructuring activities related to our equity ownership, including transaction bonuses paid in connection with the Transactions, professional fees, due diligence, public company readiness and integration activities. |
(e) | Represents fees and costs associated with various internal reorganization activities among our consolidated entities. |
(f) | Represents legal settlements that are unusual or infrequent costs associated with our operating activities. |
(g) | Represents the amortization of intangible assets recorded in connection with the 2014 Topco Acquisition and our other acquisitions. |
(h) | Represents (i) costs related to implementation of strategies for workplace safety in response to COVID-19, including employee-relief fund, additional sick pay for front-line associates, medical benefit payments for furloughed associates, and personal protective equipment; and (ii) benefits received from government grants for COVID-19 relief. |
(i) | Represents fees associated with the issuance of the New Senior Secured Credit Facilities and the Notes. For additional information, refer to Note 7 – Debt |
(j) | Represents $0.9 million and $0.9 million of costs associated with investigation and remediation activities related to the Take 5 Matter, primarily, professional fees and other related costs, respectively for the three months ended March 31, 2021 and 2020, respectively. |
(k) | Represents the tax provision or benefit associated with the adjustments above, taking into account the Company’s applicable tax rates, after excluding adjustments related to items that do not have a related tax impact. |
(l) | Represents additions to reflect our proportional share of Adjusted EBITDA related to our equity method investments and reductions to remove the Adjusted EBITDA related to the minority ownership percentage of the entities that we fully consolidate in our financial statements. |
Three Months Ended March 31, |
Year Ended December 31, |
|||||||||||||||||||
(in thousands) |
2021 |
2020 |
2020 |
2019 |
2018 |
|||||||||||||||
Net cash provided by operating activities |
$ | 29,887 | $ | 50,965 | $ | 345,730 | $ | 151,343 | $ | 126,348 | ||||||||||
Net cash used in investing activities |
(19,281 | ) | (59,842 | ) | (99,003 | ) | (61,808 | ) | (231,445 | ) | ||||||||||
Net cash (used in) provided by financing activities |
(54,514 | ) | 71,152 | (230,152 | ) | (38,208 | ) | 70,140 | ||||||||||||
Net effect of foreign currency fluctuations on cash |
(2,234 | ) | (6,883 | ) | 4,366 | 3,179 | (9,146 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net change in cash, cash equivalents and restricted cash |
$ | (46,142 | ) | $ | 55,392 | $ | 20,941 | $ | 54,506 | $ | (44,103 | ) | ||||||||
|
|
|
|
|
|
|
|
|
|
(in thousands) |
Total |
Current |
Long-Term |
|||||||||
Operating lease liabilities (1) |
$ | 65,631 | $ | 20,894 | $ | 44,737 | ||||||
Client deposits (2) |
10,706 | 10,706 | — | |||||||||
Total debt excluding deferred issuance costs (3) |
2,153,618 | 63,745 | 2,089,873 | |||||||||
Other long-term liabilities on the consolidated balance sheet |
||||||||||||
Contingent consideration (4) |
45,901 | 10,733 | 35,168 | |||||||||
Unpaid claims (5) |
64,953 | 34,401 | 30,552 | |||||||||
Holdbacks (6) |
6,268 | 5,764 | 504 | |||||||||
|
|
|
|
|
|
|||||||
Total contractual obligations |
$ | 2,347,077 | $ | 146,243 | $ | 2,200,834 | ||||||
|
|
|
|
|
|
(1) | Refer to Note 8 — Leases |
(2) | Represents payments collected from our clients, primarily, associated with market development funds that arise out of our business. |
(3) | We have an aggregate principal amount of $1.325 billion borrowing on the New Term Loan Facility, which bears interest at a floating rate, which can be either an adjusted Eurodollar rate plus an applicable margin or, at the Borrower’s option, a base rate plus an applicable margin, and $775.0 million in Senior Secured Notes, which is subject to a fixed interest rate of 6.5%. Refer to Note 7 — Debt |
financial statements for the year ended December 31, 2020 for additional information regarding the maturities of debt principal. Total debt excluding deferred issuance costs does not include the obligation of future interest payments. |
(4) | Refer to Note 6 — Other |
(5) | Represents $56.2 million of an estimated liability under our workers’ compensation programs for claims incurred but unpaid and $8.8 million of employee insurance reserves as of December 31, 2020. |
(6) | Represents $6.2 million of holdback amounts which are used to withhold a portion of the initial purchase price payment until certain post-closing conditions are satisfied and are typically settled within 24 months of the acquisition. |
• | Discounted Cash Flow Analysis (Income Model) |
• | Guideline Public Companies (Market Model) |
• | Mergers and Acquisition (Market Model) |
• | We sit at the nexus of consumer goods companies and retailers and serve as a trusted partner to both. |
• | We help our clients sell more while spending less. We make them more effective and more efficient. |
• | We win by providing best-in-class |
• | We drive productivity to provide fuel for reinvestment and growth. |
• | Simply put, we are built to do it better, cheaper and faster. |
• | federal, state, local and foreign laws and regulations involving minimum wage, health care, overtime, sick leave, lunch and rest breaks and other similar wage, benefits and hour requirements and other similar laws; |
• | Title VII of the Civil Rights Act and the Americans with Disabilities Act and regulations of the U.S. Department of Labor, the Occupational Safety & Health Administration, the U.S. Equal Employment Opportunity Commission and the equivalent state agencies and other similar laws; |
• | food and permitting matters (e.g., licensing under the Perishable Agricultural Commodities Act and regulations from the U.S. Department of Agriculture), food safety matters (e.g., federal, state and local certification and training and inspection and enforcement of standards for our associates, facilities, equipment and the products we promote), alcohol beverage marketing regulations, custom and import matters with respect to products imported to and exported from the United States; |
• | the U.S. Foreign Corrupt Practices Act, the UK Bribery Act and other similar anti-bribery and anti- kickback laws and regulations that generally prohibit companies and their intermediaries from making improper payments for the purpose of obtaining or retaining business; and |
• | federal, state and foreign anticorruption, data protection, privacy, consumer protection, content regulation and other laws and regulations, including without limitation, GDPR and the CCPA. |
Name |
Age |
Position | ||||
Tanya Domier |
55 | Chief Executive Officer and Director | ||||
Brian Stevens |
48 | Chief Financial Officer and Chief Operating Officer | ||||
Jill Griffin |
48 | President and Chief Commercial Officer | ||||
Ronald E. Blaylock |
61 | Director | ||||
Cameron Breitner |
46 | Director | ||||
Beverly F. Chase |
72 | Director | ||||
Virginie Costa |
46 | Director | ||||
Ryan Cotton |
42 | Director | ||||
Timothy J. Flynn |
48 | Director | ||||
Tiffany Han |
32 | Director | ||||
James M. Kilts |
73 | Director | ||||
Elizabeth Muñoz-Guzman |
53 | Director | ||||
Brian K. Ratzan |
50 | Director | ||||
Jonathan D. Sokoloff |
63 | Director | ||||
David J. West |
58 | Director |
• | that a majority of our board of directors consists of “independent directors,” as defined under the rules of the NASDAQ; |
• | that we have a nominating and corporate governance committee that is composed entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities; |
• | that we have a compensation committee that is composed entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities; and |
• | for an annual performance evaluation of nominating and governance committee and compensation committee. |
• | appointing, compensating, retaining, evaluating, terminating and overseeing our independent registered public accounting firm; |
• | discussing with our independent registered public accounting firm its independence from management; |
• | reviewing with our independent registered public accounting firm the scope and results of its audit; |
• | approving all audit and permissible non-audit services to be performed by our independent registered public accounting firm; |
• | overseeing the financial reporting process and discussing with management and our independent registered public accounting firm the interim and annual financial statements that we file with the SEC; |
• | reviewing and monitoring our accounting principles, accounting policies, financial and accounting controls and compliance with legal and regulatory requirements; and |
• | establishing procedures for the confidential anonymous submission of concerns regarding questionable accounting, internal controls or auditing matters. |
• | reviewing and approving the corporate goals and objectives with respect to compensation of our Chief Executive Officer; |
• | evaluating the Chief Executive Officer’s performance with respect to such approved corporate goals and objectives, and, based upon this evaluation (either alone or, if directed by the Board, in conjunction with a majority of the independent directors on the Board) setting the Chief Executive Officer’s compensation; |
• | reviewing and setting or making recommendations to the Board with respect to compensation of our other executive officers; |
• | reviewing and making recommendations to the Board with respect to director compensation; and |
• | appointing and overseeing any compensation consultants. |
• | identifying individuals qualified to become members of our board of directors, consistent with criteria approved by our board of directors; and |
• | developing and recommending to our board of directors a set of corporate governance guidelines and principles. |
• | Tanya Domier, who serves as Chief Executive Officer and is our principal executive officer; |
• | Brian Stevens, who serves as Chief Financial Officer and Chief Operating Officer and is our principal financial officer; and |
• | Jill Griffin, who serves as President and Chief Commercial Officer. |
• | encourage highly talented executives to come, stay, grow and lead, enabling us to be an employer of choice in our industry; |
• | differentiate pay for superior performers to recognize and reward individual contributions to our success; |
• | focus leadership on our long-term strategies and value creation by providing a substantial percentage of compensation weighted towards equity incentives that are subject to certain performance conditions and vesting requirements; and |
• | ensure that our total compensation is fair, reasonable and competitive relative to the various industries in which we compete for talent. |
• | base salary; |
• | annual performance-based non-equity incentive compensation; |
• | long-term equity incentive compensation; |
• | certain severance benefits; |
• | a 401(k) retirement savings plan; and |
• | health and welfare benefits and certain limited perquisites and other personal benefits. |
Named Executive Officer |
Annual Base Salary |
|||
Tanya Domier |
$ | 1,000,000 | (1) | |
Brian Stevens |
$ | 600,000 | ||
Jill Griffin |
$ | 600,000 |
(1) | Ms. Domier advised the Company Compensation Committee that it would best serve the Company for her not to receive her full salary in 2020, and the Company Compensation Committee determined with the support of Ms. Domier to reduce her base salary for 2020 by $500,000 that would otherwise have been payable under her employment agreement. This will not impact Ms. Domier’s 2021 base salary. |
Performance Level |
Annual Incentive Maximum Opportunity (as a % of annual base salary) |
|||
Below Level 1 |
0 | |||
Level 1 |
50 | % | ||
Level 2 |
100 | % | ||
Level 3 |
150 | % |
Stock |
Non-Equity Incentive Plan |
All Other |
||||||||||||||||||||||||
Name and Principal Position |
Year Salary (1) |
Bonus (2) |
Awards (3) |
Compensation |
Compensation (4) |
Total |
||||||||||||||||||||
Tanya Domier |
Chief Executive | 2020 $ | 500,000 | $ | 12,000,000 | — | $ | 1,500,000 | $ | 74,523 | $ | 14,074,523 | ||||||||||||||
Officer | 2019 $ | 850,000 | — | — | $ | 1,300,000 | $ | 68,535 | $ | 2,218,535 | ||||||||||||||||
2018 $ | 850,000 | — | — | $ | 1,020,000 | $ | 56,420 | $ | 1,926,420 | |||||||||||||||||
Brian Stevens |
Chief Financial | 2020 $ | 600,000 | $ | 5,000,000 | — | $ | 900,000 | $ | 57,755 | $ | 6,557,755 | ||||||||||||||
Officer and Chief | 2019 $ | 588,477 | — | — | $ | 880,000 | $ | 56,008 | $ | 1,524,485 | ||||||||||||||||
Operating Officer | 2018 $ | 531,911 | — | $ | 3,120,000 | $ | 685,955 | $ | 46,713 | $ | 4,384,579 | |||||||||||||||
Jill Griffin |
President and | 2020 $ | 600,000 | $ | 5,000,000 | $ | 557,500 | $ | 900,000 | $ | 53,695 | $ | 7,111,195 | |||||||||||||
Chief Commercial | 2019 $ | 574,615 | — | — | $ | 880,000 | $ | 47,187 | $ | 1,501,802 | ||||||||||||||||
Officer | 2018 $ | 439,615 | — | $ | 1,560,000 | $ | 645,000 | $ | 27,025 | $ | 2,671,640 |
(1) | Ms. Domier advised the Company Compensation Committee that it would best serve the Company for her not to receive her full salary in 2020, and the Company Compensation Committee determined with the support of Ms. Domier to reduce her base salary for 2020 by $500,000 that would otherwise have been payable under her employment agreement. |
(2) | For Ms. Domier, this represents the scheduled and accelerated anniversary bonus payments paid in 2020. For each of Mr. Stevens and Ms. Griffin, this represents the accelerated Retention Incentive Payment under the MIP in the amount of $3,000,000 and a transaction bonus of $2,000,000, both paid in 2020. |
(3) | In 2020 Ms. Griffin received a grant of Topco Common Series C-2 Units under the limited partnership agreement of Topco. There is no public market for the Common Series C-2 Units. For purposes of this disclosure, we have valued the Common Series C-2 Units using a third-party valuation on a per-unit basis of the profits interests as of the grant date, with respect to 2,500 Units granted with immediate vesting on May 6, 2020 and reflects the intrinsic value of the profits interests as of the applicable vesting date. |
(4) | Amounts in this column include the following for the year ended December 31, 2020: |
Name |
Car Allowance |
Club Membership |
401(k) Matching Contribution |
Health Reimbu- rsement |
Disability Premium |
Life Insurance Premiums |
Total |
|||||||||||||||||||||
Tanya Domier |
$ | 27,000 | $ | 12,000 | $ | 7,118 | $ | 9,930 | $ | 18,175 | $ | 300 | $ | 74,523 | ||||||||||||||
Brian Stevens |
$ | 24,000 | $ | 12,228 | $ | 8,550 | $ | 2,977 | $ | 9,700 | $ | 300 | $ | 57,755 | ||||||||||||||
Jill Griffin |
$ | 24,000 | — | $ | 8,550 | $ | 13,012 | $ | 7,833 | $ | 300 | $ | 53,695 |
All Other Stock Awards: |
||||||||||||||||||||||||
Estimated Future Payouts Under Non-Equity Incentive Plan Awards(1) |
Number of Shares or Stock or Units (#) |
Grant Date Fair Value of Awards ($)(2) |
||||||||||||||||||||||
Name |
Grant Date |
Threshold ($) |
Target ($) |
Maximum ($) |
||||||||||||||||||||
Tanya Domier |
— | 500,000 | 1,000,000 | 1,500,000 | — | — | ||||||||||||||||||
Brian Stevens |
— | 300,000 | 600,000 | 900,000 | — | — | ||||||||||||||||||
Jill Griffin |
— | 300,000 | 600,000 | 900,000 | — | — | ||||||||||||||||||
5/6/2020 | — | — | — | 2,500 | (3) | 557,500 |
(1) | Threshold, target and maximum payouts represent Level 1, Level 2 and Level 3 performance levels, respectively, regarding our annual incentive as discussed above. |
(2) | Ms. Griffin received a grant of Topco Common Series C-2 Units under the limited partnership agreement of Topco. There is no public market for the Common Series C-2 Units. For purposes of this disclosure, we have valued the Common Series C-2 Units using a third-party valuation on a per-unit basis of the profits interests as of the grant date, with respect to 2,500 Units granted with immediate vesting on May 6, 2020 and reflects the intrinsic value of the profits interests as of the applicable vesting date. |
(3) | Such units were transferred to a trust for estate planning purposes on August 28, 2020. |
Name |
Grant Date |
Number of Units That Have Not Vested (#) |
Market Value of Units that Have Not Vested ($)(5) |
|||||||||
Tanya Domier |
December 23, 2014 | 11,663.500 | (1)(2) | $ | 1,341,303 | |||||||
Brian Stevens |
December 23, 2014 | 2,500.000 | (1)(3) | $ | 287,500 | |||||||
Jill Griffin |
December 23, 2014 | 875.000 | (1)(3) | $ | 100,625 | |||||||
February 25, 2016 | 750.000 | (1)(3) | $ | 81,750 | ||||||||
February 15, 2017 | 31.250 | (1)(4) | $ | 3,188 |
(1) | Reflects unvested 20% IRR Vesting Units. The 20% IRR Vesting Units vest upon the earlier to occur of: (i) an Approved Partnership Sale or a sale of substantially all of the assets of Topco and its subsidiaries, in each case that is approved by Topco’s board of directors, or (ii) a public offering, provided that, at the time of such event, or over a staggered two-year period, the pre-tax internal rate of return to the Common Series A Limited Partners is at least 20% compounded annually with respect to the Common Series A Units held by them, based on cash proceeds received or, in respect of a sale of Topco or a sale of substantially all of its assets, available to be received by them pursuant to the definitive agreement relating thereto, and after giving effect to the vesting of the Common Series C Units in accordance with the terms of any Restricted Unit Agreement and the vesting of the Common Series D Units. For further information, see “Compensation Discussion and Analysis—Executive Compensation Program Components—Long-Term Equity Incentive Compensation—Topco Equity Awards” |
(2) | A total of 12,000 units were transferred to a trust for estate planning purposes on December 29, 2016 and April 5, 2017. |
(3) | Such units were transferred to a trust for estate planning purposes on December 27, 2016. |
(4) | Such units were transferred to a trust for estate planning purposes on April 24, 2019. |
(5) | There is no public market for the Common Series C Units. For purposes of this disclosure, we have valued the Common Series C Units using a third-party valuation on a per-unit basis as of December 31, 2020. The amount reported above under the heading “Market Value of Units That Have Not Vested” reflects the intrinsic value of the profits interests as of December 31, 2020. |
Name |
Number of Units That Vested (#)(2) |
Value Realized on Vesting ($)(1) |
||||||||||
Jill Griffin |
2,523.437 | $ | 565,914 |
(1) | There is no public market for the Common Series C Units. For purposes of this disclosure, we have valued the Common Series C Units using a third-party valuation on a per-unit basis of the profits interests as of the grant date, with respect to 2,500 Common Series C-2 Units granted with immediate vesting on May 6, 2020 and 23.437 Common Series C Units that vested on December 31, 2020. The amount reported above under the heading “Value Realized on Vesting” reflects the intrinsic value of the interests as of the applicable vesting date. |
(2) | Ms. Griffin transferred such units to a trust for estate planning purposes on various dates in 2019 and 2020. |
Name |
Benefit |
Termination without Cause or for Good Reason(2) |
Termination due to death or Disability(3) |
|||||||
Tanya Domier |
Severance pay | $ | 2,000,000 | $ | 1,000,000 | |||||
Healthcare Benefits(1) | $ | 55,881 | $ | 27,941 | ||||||
Brian Stevens |
Severance pay | $ | 900,000 | $ | 600,000 | |||||
Healthcare Benefits(1) | $ | 31,480 | $ | 21,092 | ||||||
Jill Griffin |
Severance pay | $ | 900,000 | $ | 600,000 | |||||
Healthcare Benefits(1) | $ | 34,559 | $ | 23,154 |
(1) | Reflects company portion of payments made during the severance period described below. For termination due to death or disability, healthcare benefits continue only for termination related to disability. |
(2) | The amounts in this column are payable in connection with a termination without “cause” or for “good reason” (other than “good reason” due to delivery by the Company of notice of non-renewal, in which case the severance amount would be $1,000,000 for Ms. Domier) whether before or after a change in control. Receipt of these payments and benefits is conditioned on the Named Executive Officer’s execution of a release in favor of the Company. |
(3) | The amounts in this column are payable in connection with a termination due to death or Disability whether before or after a change in control. |
Name |
Fees Earned or Paid in Cash ($) |
Stock Awards ($)(1) |
All Other Compensation ($) |
Total |
||||||||
Ronald E. Blaylock |
$ | 17,391 | $— | $— | $ | 17,391 | ||||||
Beverly F. Chase |
$ | 20,435 | $— | $— | $ | 20,435 | ||||||
Virginie Costa |
$ | 20,870 | $— | $— | $ | 20,870 | ||||||
Elizabeth Munoz-Guzman |
$ | 17,391 | $— | $— | $ | 17,391 |
(1) | No equity awards were made to directors in 2020; however, on January 5, 2021, the Board approved the grant of RSUs to certain of its eligible non-employee directors (Ronald E. Blaylock, Beverly Chase, Virginie Costa and Elizabeth Munoz-Guzman) with respect to 10,356 shares each. The RSUs are scheduled to vest on the earlier of the one-year anniversary of the date of grant or the day immediately preceding the date of the first annual meeting of the Company’s stockholders occurring after the date of grant. The number of RSU’s granted was pro-rated for the period from the date of the completion of the Transactions to June 1, 2021. |
• | each person who is known by the Company to be the beneficial owner of more than five percent (5%) of the outstanding shares of the Class A common stock; |
• | each Named Executive Officer and director of the Company; and |
• | all current executive officers and directors of the Company, as a group. |
Name and Address of Beneficial Owner (1) |
Number of Shares of Class A common stock |
Percent Owned |
||||||
Directors and Named Executive Officers Post-business combination |
||||||||
Tanya L. Domier |
— | — | ||||||
Brian Stevens |
— | — | ||||||
Jill Griffin |
— | — | ||||||
Ronald E. Blaylock |
35,356 | * | ||||||
Cameron Breitner |
— | — | ||||||
Beverly F. Chase |
10,356 | * | ||||||
Virginie Costa |
10,356 | * | ||||||
Ryan Cotton |
— | — | ||||||
Timothy J. Flynn (2) |
15,450,000 | 4.9 | % | |||||
Tiffany Han |
— | — | ||||||
James M. Kilts |
— | — | ||||||
Elizabeth Muñoz-Guzman |
10,356 | * | ||||||
Brian K. Ratzan |
— | — | ||||||
Jonathan D. Sokoloff (2) |
15,450,000 | 4.9 | % | |||||
David J. West |
— | — | ||||||
All directors and executive officers post-business combination as a group (15 individuals) |
15,475,000 | 4.9 | % | |||||
Five Percent Holders |
||||||||
Karman Topco L.P. (3) |
208,750,000 | 65.6 | % | |||||
Conyers Park II Sponsor LLC (4) |
18,483,333 | 5.8 | % |
* | Less than 1%. |
(1) | Unless otherwise noted, the business address of each of the following entities or individuals is c/o Advantage Solutions Inc., 18100 Von Karman Avenue, Suite 1000, Irvine, California 92612; provided, however, that the business address of each of Messrs. Kilts, West and Ratzan is c/o Conyers Park II |
(2) | Consists of shares of Class A common stock that were purchased in the PIPE Investment by Green Equity Investors VI, L.P. and Green Equity Investors Side VI, L.P. (collectively, the “ Green Funds Karman Coinvest Karman II Coinvest |
(3) | The board of directors of Topco, currently consisting of Cameron Breitner, Tanya Domier, Timothy Flynn, Jonathan Sokoloff, Ryan Cotton and Tiffany Han, exercises voting and dispositive power with respect to these securities. No person or entity has the right to appoint a majority of Topco’s directors. Excludes 5,000,000 shares of common stock over which Topco did not have voting and investment power until such shares vested upon achievement of a market performance condition in January, 2021. |
(4) | Includes 7,333,333 shares which may be purchased by exercising warrants that are exercisable. There are five managers of the CP Sponsor’s board of managers, including James M. Kilts, David J. West and Brian K. Ratzan. Each manager has one vote, and the approval of three of the five members of the board of managers is required to approve an action of the CP Sponsor. Under the so-called “rule of three”, if voting and dispositive decisions regarding an entity’s securities are made by three or more individuals, and a voting or dispositive decision requires the approval of a majority of those individuals, then none of the individuals is deemed a beneficial owner of the entity’s securities. This is the situation with regard to the CP Sponsor. Based upon the foregoing analysis, the CP Sponsor has determined that no individual manager of the CP Sponsor exercises voting or dispositive control over any of the securities held by the CP Sponsor, even those in which he directly holds a pecuniary interest. Accordingly, none of them will be deemed to have or share beneficial ownership of such shares. |
• | each Named Executive Officer and director of the Company; and |
• | all executive officers and directors of the Company as a group. |
Beneficial ownership of Common Series A Units of Topco |
Beneficial ownership of Common Series B Units of Topco |
Beneficial ownership of Common Series C and C-2 Units of Topco |
Beneficial ownership of Common Series D Units of Topco |
|||||||||||||||||||||||||||||
Name and Principal Position |
Number |
Percent of Common Series A Units of Topco |
Number |
Percent of Common Series B Units of Topco |
Number |
Percent of Common Series C and C-2 Units of Topco |
Number |
Percent of Common Series D Units of Topco |
||||||||||||||||||||||||
Named Executive Officers and Directors |
||||||||||||||||||||||||||||||||
Tanya Domier |
— | $ | — | 14,199.392 | (3) | 16.9 | % | 22,990.500 | (6) | 11.3 | % | — | — | |||||||||||||||||||
Brian Stevens |
— | — | 4,376.209 | (4) | 5.2 | % | 11,150.000 | (7) | 5.5 | % | — | — | ||||||||||||||||||||
Jill Griffin |
— | — | 3,211.044 | (5) | 3.8 | % | 9,068.750 | (8) | 4.4 | % | — | — | ||||||||||||||||||||
Cameron Breitner |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||
Ryan Cotton |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||
Tiffany Han |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||
Timothy J. Flynn |
792,500.000 | (1) | 39.5 | % | — | — | — | — | — | — | ||||||||||||||||||||||
James M. Kilts |
50,000.000 | (2) | 2.5 | % | — | — | — | — | 30,000.000 | (10) | 100.0 | % | ||||||||||||||||||||
Brian K. Ratzan |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||
Jonathan D. Sokoloff |
792,500.000 | (1) | 39.5 | % | — | — | — | — | — | — | ||||||||||||||||||||||
David L. West |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||
All directors and executive officers as a group (15 total) |
842,500.000 | (1)(2) | 42.0 | % | 21,786.645 | 25.9 | % | 43,209.250 | (9) | 21.1 | % | 30,000.0000 | 100.0 | % |
(1) | Represents Common Series A Units of Topco held by Green Equity Investors VI, L.P. and Green Equity Investors Side VI, L.P. (collectively, the “Green Funds”), Associates”), |
|
foregoing entities’ and individuals’ address is c/o Leonard Green & Partners, L.P., 11111 Santa Monica Boulevard, Suite 2000, Los Angeles, California 90025. |
(2) | Represents Common Series A Units of Topco held by Centerview Capital, L.P. and Centerview Employees, L.P. (collectively, the “Centerview Funds”). Mr. Kilts is a director of Topco and is a partner of Centerview Capital G.P. LLC, the managing adviser to the Centerview Funds. As such, Mr. Kilts may be deemed to beneficially own the Common Series A Units of Topco held by the Centerview Funds, and he disclaims beneficial ownership of such units. Mr. Kilt’s address is c/o Centerview Capital, L.P., 999 Vanderbilt Beach Rd., Suite 601, Naples, FL 34108. |
(3) | Includes 14,199.392 Common Series B Units held by a trust, which Ms. Domier may be deemed to indirectly beneficially own. |
(4) | Includes 4,376.209 Common Series B Units held by a trust (the “Stevens Trust”), which Mr. Stevens may be deemed to indirectly beneficially own. |
(5) | Includes 3,211.044 Common Series B Units held by a Trust (the “Griffin Trust”), which Ms. Griffin may be deemed to indirectly beneficially own. |
(6) | Includes 22,990.500 vested Common Series C Units that have been granted to Ms. Domier and excludes 11,663.500 Common Series C Units that have been granted to Ms. Domier but we expect to remain subject to certain vesting requirements as described in “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies and Estimates—Equity-Based Compensation” and elsewhere in this prospectus. |
(7) | Includes 6,150.000 vested Common Series C Units and 5,000.000 Common Series C-2 Units in each case held by the Stevens Trust, and excludes 2,050.000 Common Series C Units held by the Stevens Trust that have been granted to Mr. Stevens but we expect to remain subject to certain vesting requirements as described in “Management’s Discussion and Analysis of Financial Condition and Results of Operations— Critical Accounting Policies and Estimates—Equity-Based Compensation” and elsewhere in this prospectus. |
(8) | Includes 4,068.750 vested Common Series C Units and 5,000.000 Common Series C-2 Units held by the Griffin Trust and excludes 1,356.250 Common Series C Units held by the Griffin Trust that have been granted to Ms. Griffin but we expect to remain subject to certain vesting requirements as described in “Management’s Discussion and Analysis of Financial Condition and Results of Operations— Critical Accounting Policies and Estimates—Equity-Based Compensation” and elsewhere in this prospectus. |
(9) | Includes 33,209.250 Common Series C Units that have been granted to all directors and executive officers as a group and we expect to vest within 60 days of March 31, 2021 and 10,000.000 Common Series C-2 Units that have been granted to all directors and executive officers as a group, and excludes 15,069.750 Common Series C Units that have been granted to all directors and executive officers as a group but we expect to remain subject to certain vesting requirements as described in “Management’s Discussion, and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies and Estimates— Equity-Based Compensation” |
(10) | Represents Common Series D Units of Topco held by the Centerview Funds. Mr. Kilts was a director of Topco and is a partner of Centerview Capital G.P. LLC, the managing adviser to the Centerview Funds. As such, Mr. Kilts may be deemed to beneficially own the Common Series D Units of Topco held by the Centerview Funds, and he disclaims beneficial ownership of such units. Mr. Kilt’s address is c/o Centerview Capital, L.P., 999 Vanderbilt Beach Rd., Suite 601, Naples, FL 34108. |
Name of Selling Stockholder |
Class A Common Stock Beneficially Owned As of January 31, 2021 |
Number of Shares of Class A Common Stock Being Offered (1) |
Class A Common Stock Beneficially Owned After the Offered Shares of Class A Common Stock are Sold |
|||||||||||||
Number |
Percent |
|||||||||||||||
Antara Capital Master Fund LP |
1,000,000 | 1,000,000 | — | — | ||||||||||||
The Baupost Group, L.L.C. (2) |
12,500,000 | 12,500,000 | — | — | ||||||||||||
Brookdale Global Opportunity Fund (3) |
264,000 | 264,000 | — | — | ||||||||||||
Brookdale International Partners, L.P. (4) |
536,000 | 536,000 | — | — | ||||||||||||
ClearBridge Small Cap CIF |
57,323 | 57,323 | — | — | ||||||||||||
ClearBridge Small Cap Fund |
1,279,975 | 1,279,975 | — | — | ||||||||||||
ClearBridge Small Cap Value Fund |
119,894 | 119,894 | — | — | ||||||||||||
Evan Ratner & Nicole Feig JTWROS |
10,000 | 10,000 | — | — | ||||||||||||
Guardian Small Cap Core VIP Fund |
342,808 | 342,808 | — | — | ||||||||||||
Highmark Long/Short Equity 17 Limited |
3,000,000 | 3,000,000 | — | — | ||||||||||||
Jack Murphy & Jennifer Murphy TIC |
25,000 | 25,000 | — | — | ||||||||||||
John Mackin |
10,000 | 10,000 | — | — | ||||||||||||
Jane Street Global Trading, LLC |
804,540 | 800,000 | 4,540 | * | ||||||||||||
MassMutual Select Funds – MassMutual Select T. Rowe Price Small and Mid Cap Blend Fund (5) |
52,173 | 24,151 | 28,022 | * | ||||||||||||
Maven Investment Partners Us Ltd – New York Branch |
300,000 | 300,000 | — | — | ||||||||||||
Nineteen77 Global Merger Arbitrage Master Limited |
600,000 | 600,000 | — | — | ||||||||||||
Nineteen77 Global Multi-Strategy Alpha Master Limited |
600,000 | 600,000 | — | — |
Name of Selling Stockholder |
Class A Common Stock Beneficially Owned As of January 31, 2021 |
Number of Shares of Class A Common Stock Being Offered (1) |
Class A Common Stock Beneficially Owned After the Offered Shares of Class A Common Stock are Sold |
|||||||||||||
Number |
Percent |
|||||||||||||||
Norges Bank |
6,446,300 | 6,446,300 | — | — | ||||||||||||
Prentice Long/Short Equity Master II LP |
700,000 | 700,000 | — | — | ||||||||||||
Samuel Hendel |
10,000 | 10,000 | — | — | ||||||||||||
Senator Global Opportunity Master Fund LP |
3,451,114 | 3,451,114 | — | — | ||||||||||||
T. Rowe Price Small-Cap Value Fund, Inc. (5) |
3,281,923 | 2,023,333 | 1,258,590 | * | ||||||||||||
T. Rowe Price U.S. Small-Cap Value Equity Trust (5) |
1,109,932 | 657,279 | 452,653 | * | ||||||||||||
T. Rowe Price U.S. Equities Trust (5) |
67,320 | 43,928 | 23,392 | * | ||||||||||||
T. Rowe Price Global Consumer Fund (5) |
34,000 | 21,214 | 12,786 | * | ||||||||||||
Trust U/W Carl M. Loeb FBO Arthur Loeb |
40,000 | 40,000 | — | — | ||||||||||||
Trust U/W Carl M. Loeb FBO Elisabeth Levin |
80,000 | 80,000 | — | — | ||||||||||||
Trust U/W Carl M. Loeb FBO Jean L. Troubh |
20,000 | 20,000 | — | — | ||||||||||||
Trust U/W Frances L. Loeb FBO Arthur Loeb |
35,000 | 35,000 | — | — | ||||||||||||
Ulysses Offshore Fund Ltd. |
10,000 | 10,000 | — | — | ||||||||||||
Ulysses Partners LP |
50,000 | 50,000 | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total Shares |
36,837,302 |
35,057,319 |
1,779,983 |
|||||||||||||
|
|
|
|
|
|
|
|
* | Less than 1%. |
(1) | The amounts set forth in this column are the number of shares of Common Stock that may be offered by each Selling Stockholder using this prospectus. These amounts do not represent any other shares of our Common Stock that the Selling Stockholder may own beneficially or otherwise. |
(2) | The Baupost Group, L.L.C. is a registered investment adviser and acts as the investment adviser to certain private investment limited partnerships on whose behalf these securities were purchased. |
(3) | Weiss Asset Management LP (“ WAM BGO |
(4) | BIP GP LLC is the general partner of Brookdale International Partners, L.P. (“ BIP WAM |
(5) | T. Rowe Price Associates, Inc. (“ T. Rowe Price |
financial services holding company. T. Rowe Price Investment Services, Inc. (“ TRPIS |
• | in whole and not in part; |
• | a price of $0.01 per warrant; |
• | upon not less than 30 days’ prior written notice of redemption (the “ 30-day redemption period” |
• | if, and only if, the reported closing price of the Class A common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending three business days before we send the notice of redemption to the warrant holders. |
• | in whole and not in part; |
• | at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants prior to redemption and receive that number of shares determined by reference to the table below, based on the redemption date and the “fair market value” of our Class A common stock except as otherwise described below; |
• | if, and only if, the last reported sale price of our Class A common stock equals or exceeds $10.00 per share (as adjusted per stock splits, stock dividends, reorganizations, reclassifications, recapitalizations and the like) on the trading day prior to the date on which we send the notice of redemption to the warrant holders; and |
• | if, and only if, there is an effective registration statement covering the shares of Class A common stock issuable upon exercise of the warrants and a current prospectus relating thereto available throughout the 30-day period after written notice of redemption is given, or the Company has elected to require the exercise the warrants on a “cashless basis”. |
Redemption Date (period to expiration of warrants) |
Fair Market Value of Class A common stock |
|||||||||||||||||||||||||||||||||||
10.00 |
11.00 |
12.00 |
13.00 |
14.00 |
15.00 |
16.00 |
17.00 |
18.00 |
||||||||||||||||||||||||||||
57 months |
0.257 | 0.277 | 0.294 | 0.310 | 0.324 | 0.337 | 0.348 | 0.358 | 0.365 | |||||||||||||||||||||||||||
54 months |
0.252 | 0.272 | 0.291 | 0.307 | 0.322 | 0.335 | 0.347 | 0.357 | 0.365 | |||||||||||||||||||||||||||
51 months |
0.246 | 0.268 | 0.287 | 0.304 | 0.320 | 0.333 | 0.346 | 0.357 | 0.365 | |||||||||||||||||||||||||||
48 months |
0.241 | 0.263 | 0.283 | 0.301 | 0.317 | 0.332 | 0.344 | 0.356 | 0.365 | |||||||||||||||||||||||||||
45 months |
0.235 | 0.258 | 0.279 | 0.298 | 0.315 | 0.330 | 0.343 | 0.356 | 0.365 | |||||||||||||||||||||||||||
42 months |
0.228 | 0.252 | 0.274 | 0.294 | 0.312 | 0.328 | 0.342 | 0.355 | 0.364 | |||||||||||||||||||||||||||
39 months |
0.221 | 0.246 | 0.269 | 0.290 | 0.309 | 0.325 | 0.340 | 0.354 | 0.364 | |||||||||||||||||||||||||||
36 months |
0.213 | 0.239 | 0.263 | 0.285 | 0.305 | 0.323 | 0.339 | 0.353 | 0.364 | |||||||||||||||||||||||||||
33 months |
0.205 | 0.232 | 0.257 | 0.280 | 0.301 | 0.320 | 0.337 | 0.352 | 0.364 | |||||||||||||||||||||||||||
30 months |
0.196 | 0.224 | 0.250 | 0.274 | 0.297 | 0.316 | 0.335 | 0.351 | 0.364 | |||||||||||||||||||||||||||
27 months |
0.185 | 0.214 | 0.242 | 0.268 | 0.291 | 0.313 | 0.332 | 0.350 | 0.364 | |||||||||||||||||||||||||||
24 months |
0.173 | 0.204 | 0.233 | 0.260 | 0.285 | 0.308 | 0.329 | 0.348 | 0.364 | |||||||||||||||||||||||||||
21 months |
0.161 | 0.193 | 0.223 | 0.252 | 0.279 | 0.304 | 0.326 | 0.347 | 0.364 | |||||||||||||||||||||||||||
18 months |
0.146 | 0.179 | 0.211 | 0.242 | 0.271 | 0.298 | 0.322 | 0.345 | 0.363 | |||||||||||||||||||||||||||
15 months |
0.130 | 0.164 | 0.197 | 0.230 | 0.262 | 0.291 | 0.317 | 0.342 | 0.363 | |||||||||||||||||||||||||||
12 months |
0.111 | 0.146 | 0.181 | 0.216 | 0.250 | 0.282 | 0.312 | 0.339 | 0.363 | |||||||||||||||||||||||||||
9 months |
0.090 | 0.125 | 0.162 | 0.199 | 0.237 | 0.272 | 0.305 | 0.336 | 0.362 | |||||||||||||||||||||||||||
6 months |
0.065 | 0.099 | 0.137 | 0.178 | 0.219 | 0.259 | 0.296 | 0.331 | 0.362 | |||||||||||||||||||||||||||
3 months |
0.034 | 0.065 | 0.104 | 0.150 | 0.197 | 0.243 | 0.286 | 0.326 | 0.361 | |||||||||||||||||||||||||||
0 months |
— | — | 0.042 | 0.115 | 0.179 | 0.233 | 0.281 | 0.323 | 0.361 |
• | prior to such time, our board of directors approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder; |
• | upon consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of our voting stock outstanding at the time the transaction commenced, excluding certain shares; or |
• | at or subsequent to that time, the business combination is approved by our board of directors and by the affirmative vote of holders of at least 66 2/3% of our outstanding voting stock that is not owned by the interested stockholder. |
• | purchases by a broker-dealer as principal and resale by such broker-dealer for its own account pursuant to this prospectus; |
• | ordinary brokerage transactions and transactions in which the broker solicits purchasers; |
• | block trades in which the broker-dealer so engaged will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction; |
• | an over-the-counter |
• | through trading plans entered into by a Selling Stockholder pursuant to Rule 10b5-1 under the Exchange Act, that are in place at the time of an offering pursuant to this prospectus and any applicable prospectus supplement hereto that provide for periodic sales of their securities on the basis of parameters described in such trading plans; |
• | to or through underwriters or broker-dealers; |
• | in “at the market” offerings, as defined in Rule 415 under the Securities Act, at negotiated prices, at prices prevailing at the time of sale or at prices related to such prevailing market prices, including sales made directly on a national securities exchange or sales made through a market maker other than on an exchange or other similar offerings through sales agents; |
• | in privately negotiated transactions; |
• | in options transactions; |
• | through a combination of any of the above methods of sale; or |
• | any other method permitted pursuant to applicable law. |
Page |
||||
Advantage Solutions Inc. Consolidated Financial Statements |
||||
F-2 | ||||
Audited Consolidated Financial Statements as of December 31, 2020 and 2019 and for the years ended December 31, 2020, 2019 and 2018 |
||||
F-6 |
||||
F-7 |
||||
F-8 |
||||
F-9 |
||||
F-10 |
||||
F-58 |
||||
Unaudited Condensed Financial Statements for the three months ended March 31, 2021 and 2020 |
||||
F-62 |
||||
F-63 |
||||
F-64 |
||||
F-65 |
||||
F-66 |
(in thousands, except per share data) |
December 31, 2020 |
December 31, 2019 |
||||||
ASSETS |
||||||||
Current assets |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Restricted cash |
||||||||
Accounts receivable, net of allowance for expected credit losses of $ |
||||||||
Prepaid expenses and other current assets |
||||||||
Total current assets |
||||||||
Property and equipment, net |
||||||||
Goodwill |
||||||||
Other intangible assets, net |
||||||||
Investments in unconsolidated affiliates |
||||||||
Other assets |
||||||||
Total assets |
$ | $ | ||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
||||||||
Current liabilities |
||||||||
Current portion of long-term debt |
$ | $ | ||||||
Accounts payable |
||||||||
Accrued compensation and benefits |
||||||||
Other accrued expenses |
||||||||
Deferred revenues |
||||||||
Total current liabilities |
||||||||
Long-term debt, net of current portion |
||||||||
Deferred income tax liabilities, net |
||||||||
Warrant liability |
— | |||||||
Other long-term liabilities |
||||||||
Total liabilities |
||||||||
Commitments and contingencies (Note 17) |
||||||||
Equity attributable to stockholders of Advantage Solutions Inc. |
||||||||
Preferred stock, |
— | |||||||
Common stock, $ |
||||||||
Additional paid in capital |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
Loans to Karman Topco L.P. |
( |
) | ( |
) | ||||
Accumulated other comprehensive income (loss) |
( |
) | ||||||
Total equity attributable to stockholders of Advantage Solutions Inc. |
||||||||
Nonredeemable noncontrolling interest |
||||||||
Total stockholders’ equity |
||||||||
Total liabilities and stockholders’ equity |
$ | $ | ||||||
Years Ended December 31, |
||||||||||||
(in thousands, except share and per share data) |
2020 |
2019 |
2018 |
|||||||||
Revenues |
$ | $ | $ | |||||||||
Cost of revenues (exclusive of depreciation and amortization shown separately below) |
||||||||||||
Selling, general, and administrative expenses |
||||||||||||
Impairment of goodwill and indefinite-lived assets |
— | — | ||||||||||
(Recovery from) loss on Take 5 |
( |
) | — | |||||||||
Depreciation and amortization |
||||||||||||
|
|
|
|
|
|
|||||||
Total expenses |
||||||||||||
|
|
|
|
|
|
|||||||
Operating income (loss) |
( |
) | ||||||||||
Other expenses: |
||||||||||||
Change in fair value of warrant liability |
— | — | ||||||||||
Interest expense, net |
||||||||||||
|
|
|
|
|
|
|||||||
Total other expenses |
||||||||||||
|
|
|
|
|
|
|||||||
Loss before income taxes |
( |
) | ( |
) | ( |
) | ||||||
(Benefit from) provision for income taxes |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Net loss |
( |
) | ( |
) | ( |
) | ||||||
Less: net income attributable to noncontrolling interest |
||||||||||||
|
|
|
|
|
|
|||||||
Net loss attributable to stockholders of Advantage Solutions Inc. |
( |
) | ( |
) | ( |
) | ||||||
Other comprehensive income (loss), net tax: |
||||||||||||
Foreign currency translation adjustments |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Total comprehensive loss attributable to stockholders of Advantage Solutions Inc. |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
|
|
|
|
|
|
|||||||
Net loss per common share: |
||||||||||||
Basic and diluted |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
|
|
|
|
|
|
|||||||
Weighted-average number of common shares: |
||||||||||||
Basic and diluted |
||||||||||||
|
|
|
|
|
|
(in thousands, except share data) |
Common Stock |
Additional Paid-in Capital |
Retained Earnings (Deficit) |
Loans to Topco |
Accumulated Other Comprehensive Income (Loss) |
Advantage Solutions Inc. Stockholders’ Equity |
Nonredeemable noncontrolling Interests |
Total Stockholders’ Equity |
||||||||||||||||||||||||||||
Shares |
Amount |
|||||||||||||||||||||||||||||||||||
Balance at January 1, 2018, as originally reported |
$ | — | $ | $ | $ | ( |
) | $ | ( |
) | $ | $ | $ | |||||||||||||||||||||||
Retroactive application of recapitalization |
( |
) | — | — | — | — | — | — | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Balance at January 1, 2018, as adjusted |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Comprehensive loss |
||||||||||||||||||||||||||||||||||||
Net (loss) income |
— | — | — | ( |
) | — | — | ( |
) | ( |
) | |||||||||||||||||||||||||
Foreign currency translation adjustments |
— | — | — | — | — | ( |
) | ( |
) | ( |
) | ( |
) | |||||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
Total comprehensive (loss) income |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
Increase in noncontrolling interest |
— | — | — | — | — | — | — | |||||||||||||||||||||||||||||
Redemption of noncontrolling interest |
— | — | ( |
) | — | — | — | ( |
) | ( |
) | ( |
) | |||||||||||||||||||||||
Loans to Karman Topco L.P. |
— | — | — | — | ( |
) | — | ( |
) | — | ( |
) | ||||||||||||||||||||||||
Equity-based compensation |
— | — | ( |
) | — | — | — | ( |
) | — | ( |
) | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Balance at December 31, 2018 |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Comprehensive loss |
||||||||||||||||||||||||||||||||||||
Net (loss) income |
— | — | — | ( |
) | — | — | ( |
) | ( |
) | |||||||||||||||||||||||||
Foreign currency translation adjustments |
— | — | — | — | — | |||||||||||||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
Total comprehensive (loss) income |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
Increase in noncontrolling interest |
— | — | — | — | — | — | — | |||||||||||||||||||||||||||||
Redemption of noncontrolling interest |
— | — | ( |
) | — | — | — | ( |
) | ( |
) | ( |
) | |||||||||||||||||||||||
Loans to Karman Topco L.P. |
— | — | — | — | ( |
) | — | ( |
) | — | ( |
) | ||||||||||||||||||||||||
Equity-based compensation |
— | — | — | — | — | — | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Balance at December 31, 2019 |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Comprehensive loss |
||||||||||||||||||||||||||||||||||||
Net (loss) income |
— | — | — | ( |
) | — | — | ( |
) | ( |
) | |||||||||||||||||||||||||
Foreign currency translation adjustments |
— | — | — | — | — | |||||||||||||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
Total comprehensive (loss) income |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
Recapitalization transaction, net of fees and deferred taxes |
— | — | — | — | ||||||||||||||||||||||||||||||||
Issuance of performance shares |
( |
) | — | — | — | — | — | — | ||||||||||||||||||||||||||||
Loans to Karman Topco L.P. |
— | — | — | — | ( |
) | — | ( |
) | — | ( |
) | ||||||||||||||||||||||||
Equity-based compensation |
— | — | — | — | — | — | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Balance at December 31, 2020 |
$ | $ | $ | ( |
) | $ | ( |
) | $ | $ | $ | $ | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
||||||||||||
(in thousands) |
2020 |
2019 |
2018 |
|||||||||
CASH FLOWS FROM OPERATING ACTIVITIES |
||||||||||||
Net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Adjustments to reconcile net loss to net cash provided by operating activities |
||||||||||||
Noncash interest expense |
||||||||||||
Extinguishment costs related to repayment of First and Second Lien Credit Agreements |
— | — | ||||||||||
Impairment of goodwill and long-lived assets |
— | — | ||||||||||
Loss on Take 5 |
— | — | ||||||||||
Depreciation and amortization |
||||||||||||
Changes in fair value of warrant liability |
— | — | ||||||||||
Fair value adjustments related to contingent consideration |
( |
) | ||||||||||
Deferred income taxes |
( |
) | ( |
) | ( |
) | ||||||
Equity-based compensation |
( |
) | ||||||||||
Equity in earnings of unconsolidated affiliates |
( |
) | ( |
) | ( |
) | ||||||
Distribution received from unconsolidated affiliates |
||||||||||||
Loss on disposal of property and equipment |
— | — | ||||||||||
Loss on divestiture |
— | — | ||||||||||
Changes in operating assets and liabilities, net of effects from purchases of businesses: |
||||||||||||
Accounts receivable |
( |
) | ||||||||||
Prepaid expense and other assets |
( |
) | ||||||||||
Accounts payable |
( |
) | ||||||||||
Accrued compensation and benefits |
( |
) | ||||||||||
Deferred revenues |
||||||||||||
Other accrued expenses and other liabilities |
( |
) | ( |
) | ( |
) | ||||||
Net cash provided by operating activities |
||||||||||||
CASH FLOWS FROM INVESTING ACTIVITIES |
||||||||||||
Purchase of businesses, net of cash acquired |
( |
) | ( |
) | ( |
) | ||||||
Purchase of investment in unconsolidated affiliates |
— | ( |
) | ( |
) | |||||||
Purchase of property and equipment |
( |
) | ( |
) | ( |
) | ||||||
Proceeds from divestiture |
— | |||||||||||
Return on investments from unconsolidated affiliates |
— | — | ||||||||||
Net cash used in investing activities |
( |
) | ( |
) | ( |
) | ||||||
CASH FLOWS FROM FINANCING ACTIVITIES |
||||||||||||
Borrowings under lines of credit |
||||||||||||
Payments on lines of credit |
( |
) | ( |
) | ( |
) | ||||||
Proceeds from accounts receivable securitization facility |
— | — | ||||||||||
Payment under accounts receivable securitization facility |
( |
) | — | — | ||||||||
Proceeds from issuance of long-term debt |
— | — | ||||||||||
Proceeds from government loans for COVID-19 relief |
— | — | ||||||||||
Proceeds from new borrowings under the New Senior Secured Credit Facilities |
— | — | ||||||||||
Principal payments on long-term debt |
( |
) | ( |
) | ( |
) | ||||||
Proceeds from recapitalization, net of fees |
— | — | ||||||||||
Settlement of Daymon credit agreement |
— | — | ( |
) | ||||||||
Contingent consideration payments |
( |
) | ( |
) | ( |
) | ||||||
Financing fees paid |
( |
) | — | ( |
) | |||||||
Holdback payments |
( |
) | ( |
) | ( |
) | ||||||
Contribution from noncontrolling interest |
— | — | ||||||||||
Redemption of noncontrolling interest |
— | ( |
) | ( |
) | |||||||
Net cash (used in) provided by financing activities |
( |
) | ( |
) | ||||||||
Net effect of foreign currency fluctuations on cash |
( |
) | ||||||||||
Net change in cash, cash equivalents and restricted cash |
( |
) | ||||||||||
Cash, cash equivalents and restricted cash, beginning of period |
||||||||||||
Cash, cash equivalents and restricted cash, end of period |
$ | $ | $ | |||||||||
SUPPLEMENTAL CASH FLOW INFORMATION |
||||||||||||
Cash payments for interest |
$ | $ | $ | |||||||||
Cash payments for income taxes |
$ | $ | $ | |||||||||
Non-cash proceeds from divestitures |
$ | — | $ | — | $ | |||||||
Purchase of property and equipment recorded in accounts payable and accrued expenses |
$ | $ | $ | |||||||||
Deferred taxes related to transaction costs in connection with recapitalization |
$ | $ | — | $ | — | |||||||
Fair value of liability for private placement warrants acquired at Closing |
$ | $ | — | $ | — | |||||||
Note payable related to settlement of contingent consideration |
$ | $ | — | $ | — |
(in thousands except share data) |
December 31, 2020 |
Adjustments |
December 31, 2020 |
|||||||||
(As Previously Reported) |
(As Revised) |
|||||||||||
Warrant liability |
$ | $ | (a) | $ | ||||||||
Total liabilities |
$ | $ | $ | |||||||||
Additional paid in capital |
$ | $ | ( |
)(a) | $ | |||||||
Accumulated deficit |
$ | ( |
) | $ | ( |
)(a) | $ | ( |
) | |||
Total equity attributable to stockholders of Advantage Solutions Inc. |
$ | $ | ( |
) | $ | |||||||
Total stockholders’ equity |
$ | $ | ( |
) | $ |
(in thousands, except per share data) |
For the Year Ended December 31, 2020 |
Adjustments |
For the Year Ended December 31, 2020 |
|||||||||
(As Previously Reported) |
(As Revised) |
|||||||||||
Change in fair value of warrant liability |
$ | $ | (a) | $ | ||||||||
Total other expenses |
$ | $ | $ | |||||||||
Loss before income taxes |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Net loss attributable to stockholders of Advantage Solutions Inc. |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Total comprehensive loss attributable to stockholders of Advantage Solutions Inc. |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Net loss per common share: |
||||||||||||
Basic and diluted |
$ | ( |
) | $ | ( |
) | $ | ( |
) |
(in thousands) |
For the Year Ended December 31, 2020 |
Adjustments |
For the Year Ended December 31, 2020 |
|||||||||
(As Previously Reported) |
(As Revised) |
|||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES |
||||||||||||
Net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Adjustments to reconcile net loss to net cash provided by operating activities |
||||||||||||
Changes in fair value of warrant liability |
(a) | |||||||||||
Net cash provided by operating activities |
$ | $ | ||||||||||
SUPPLEMENTAL CASH FLOW INFORMATION |
||||||||||||
Fair value of liability for private placement warrants acquired at Closing |
$ | $ | (a) | $ |
(a) | The adjustments reflect the revision to record the initial warrant liability of the private placement warrants and to remeasure the warrant liability to the fair value as of December 31, 2020. The initial fair value of the private placement warrants of $ |
December 31, |
||||||||||||
(in thousands) |
2020 |
2019 |
2018 |
|||||||||
Cash and cash equivalents |
$ | $ | $ | |||||||||
Restricted cash |
||||||||||||
Total cash, cash equivalents and restricted cash |
$ | $ | $ |
Leasehold improvements |
||||
Furniture and fixtures |
||||
Computer hardware and other equipment |
||||
Software |
Year Ended December 31, |
||||||||||||
(in thousands) |
2020 |
2019 |
2018 |
|||||||||
Sales brand-centric services |
$ | $ | $ | |||||||||
Sales retail-centric services |
||||||||||||
Total sales revenues |
||||||||||||
Marketing brand-centric services |
||||||||||||
Marketing retail-centric services |
||||||||||||
Total marketing revenues |
||||||||||||
Total revenues |
$ | $ | $ | |||||||||
Year Ended December 31, |
||||||||||||
(in thousands, except share and earnings per share data) |
2020 |
2019 |
2018 |
|||||||||
Basic and diluted: |
||||||||||||
Net loss attributable to stockholders |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Weighted average common shares outstanding |
||||||||||||
Basic and diluted loss per common share |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Level 1 | — | Quoted prices in active markets for identical assets or liabilities. | ||
Level 2 | — | Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. | ||
Level 3 | — | Inputs that are generally unobservable and typically reflect management’s estimate of assumptions that market participants would use in pricing the asset or liability. |
(in thousands) |
||||
Consideration: |
||||
Cash |
$ | |||
Holdbacks |
||||
Fair value of contingent consideration |
||||
Total consideration |
$ | |||
Recognized amounts of identifiable assets acquired and liabilities assumed: |
||||
Assets |
||||
Accounts receivable |
$ | |||
Other assets |
||||
Property and equipment |
||||
Identifiable intangible assets |
||||
Total assets |
||||
Liabilities |
||||
Total liabilities |
||||
Total identifiable net assets |
||||
Goodwill arising from acquisitions |
$ | |||
(in thousands) |
Amount |
Weighted Average Useful Life |
||||||
Client relationships |
$ | |||||||
(in thousands) |
||||
Consideration: |
||||
Cash |
$ | |||
Holdbacks |
||||
Fair value of contingent consideration |
||||
Total consideration |
$ | |||
Recognized amounts of identifiable assets acquired and liabilities assumed: |
||||
Assets |
||||
Accounts receivable |
$ | |||
Other assets |
||||
Identifiable intangible assets |
||||
Total assets |
||||
(in thousands) |
||||
Liabilities |
||||
Accounts payable |
||||
Accrued compensation and benefits |
||||
Deferred revenue |
||||
Long-term debt |
||||
Deferred income tax liabilities |
||||
Noncontrolling interest and other liabilities |
||||
Total liabilities and noncontrolling interest |
||||
Total identifiable net assets |
||||
Goodwill arising from acquisitions |
$ | |||
(in thousands) |
Amount |
Weighted Average Useful Life |
||||||
Client relationships |
$ | |||||||
Trade names |
||||||||
Total identifiable intangible assets |
$ | |||||||
Twelve Months Ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
(in thousands, except per share data) |
||||||||||||
Total revenues |
$ | $ | $ | |||||||||
Net loss attributable to stockholders of Advantage Solutions Inc. |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Basic and diluted earnings per share |
$ | ( |
) | $ | ( |
) | $ | ( |
) |
(in thousands) |
Sales |
Marketing |
Total |
|||||||||
Gross carrying amount as of December 31, 2019 |
$ | $ | $ | |||||||||
Accumulated impairment charge (1) |
( |
) | — | ( |
) | |||||||
|
|
|
|
|
|
|||||||
Balance at December 31, 2019 |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|||||||
Acquisitions |
||||||||||||
Foreign exchange translation effects |
— | |||||||||||
|
|
|
|
|
|
|||||||
Balance at December 31, 2020 |
$ | $ | $ | |||||||||
|
|
|
|
|
|
(in thousands) |
Sales |
Marketing |
Total |
|||||||||
Gross carrying amount as of December 31, 2018 |
$ | $ | $ | |||||||||
Accumulated impairment charge (1) |
( |
) | — | ( |
) | |||||||
|
|
|
|
|
|
|||||||
Balance at December 31, 2018 |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|||||||
Acquisitions |
||||||||||||
Foreign exchange translation effects |
( |
) | ||||||||||
Foreign exchange translation effects |
— | |||||||||||
|
|
|
|
|
|
|||||||
Balance at December 31, 2019 |
$ | $ | $ | |||||||||
|
|
|
|
|
|
(1) | During the fiscal year ended December 31, 2018, the Company recognized a non-cash goodwill impairment charge of $ |
December 31, 2020 |
||||||||||||||||||||
(in thousands) |
Weighted Average Useful Life |
Gross Carrying Value |
Accumulated Amortization |
Accumulated Impairment Charges |
Net Carrying Value |
|||||||||||||||
Finite-lived intangible assets: |
||||||||||||||||||||
Client relationships |
$ | $ | $ | — | $ | |||||||||||||||
Trade names |
— | |||||||||||||||||||
Developed technology |
— | |||||||||||||||||||
Covenant not to compete |
— | |||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total finite-lived intangible assets |
— | |||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Indefinite-lived intangible assets: |
||||||||||||||||||||
Trade names |
— | |||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total other intangible assets |
$ | $ | $ | $ | ||||||||||||||||
|
|
|
|
|
|
|
|
December 31, 2019 |
||||||||||||||||||||
(in thousands) |
Weighted Average Useful Life |
Gross Carrying Value |
Accumulated Amortization |
Accumulated Impairment Charges |
Net Carrying Value |
|||||||||||||||
Finite-lived intangible assets: |
||||||||||||||||||||
Client relationships |
$ | $ | $ | — | $ | |||||||||||||||
Trade names |
— | |||||||||||||||||||
Developed technology |
— | |||||||||||||||||||
Covenant not to compete |
— | |||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total finite-lived intangible assets |
— | |||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Indefinite-lived intangible assets: |
||||||||||||||||||||
Trade names |
— | |||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total other intangible assets |
$ | $ | $ | $ | ||||||||||||||||
|
|
|
|
|
|
|
|
(in thousands) |
||||
2021 |
||||
2022 |
||||
2023 |
||||
2024 |
||||
2025 |
||||
Thereafter |
||||
|
|
|||
Total amortization expense |
$ | |||
|
|
December 31, |
||||||||
(in thousands) | 2020 |
2019 |
||||||
Inventory |
$ | $ | ||||||
Prepaid expenses |
||||||||
Taxes |
||||||||
Miscellaneous receivables |
||||||||
Interest rate cap |
— | |||||||
Workers’ compensation receivables |
||||||||
Other current assets |
||||||||
Total prepaid expenses and other current assets |
$ | $ | ||||||
December 31, |
||||||||
(in thousands) | 2020 |
2019 |
||||||
Operating lease right-of-use |
$ | $ | ||||||
Deposits |
||||||||
Contingent consideration receivable |
— | |||||||
Workers’ compensation receivable |
||||||||
Other long-term assets |
||||||||
Total other assets |
$ | $ | ||||||
December 31, |
||||||||
(in thousands) | 2020 |
2019 |
||||||
Software |
$ | $ | ||||||
Computer hardware |
||||||||
Leasehold improvements |
||||||||
Furniture, fixtures, and other |
||||||||
Total property and equipment |
||||||||
Less: accumulated depreciation |
( |
) | ( |
) | ||||
Total property and equipment, net |
$ | $ | ||||||
December 31, |
||||||||
(in thousands) | 2020 |
2019 |
||||||
Interest rate cap and accrued interest payable |
$ | $ | ||||||
Operating lease liability |
||||||||
Rebates due to retailers |
||||||||
Contingent consideration |
||||||||
Client deposits |
||||||||
Client refunds related to the Take 5 Matter |
||||||||
Employee insurance reserves |
||||||||
Taxes |
||||||||
Holdbacks |
||||||||
Note payable related to contingent consideration |
||||||||
Restructuring charges |
||||||||
Other accrued expenses |
||||||||
Total other accrued expenses |
$ | $ | ||||||
December 31, |
||||||||
2020 |
2019 |
|||||||
(in thousands) | ||||||||
Operating lease liability |
$ | $ | ||||||
Contingent consideration |
||||||||
Workers’ compensation and other insurance reserves |
||||||||
Deferred employer social security taxes |
— | |||||||
Interest rate cap |
||||||||
Holdbacks |
||||||||
Taxes |
||||||||
Other long-term liabilities |
||||||||
|
|
|
|
|||||
Total other long-term liabilities |
$ | $ | ||||||
|
|
|
|
Year Ended December 31, |
||||||||
(in thousands) |
2020 |
2019 |
||||||
Beginning of the period |
$ | $ | ||||||
Fair value of acquisitions |
||||||||
Payments |
( |
) | ( |
) | ||||
Note issuance for settlements |
( |
) | ( |
) | ||||
Changes in fair value |
||||||||
Foreign exchange translation effects |
( |
) | ( |
) | ||||
|
|
|
|
|||||
End of the period |
$ | $ | ||||||
|
|
|
|
December 31, |
December 31, |
|||||||
(in thousands) |
2020 |
2019 |
||||||
New Term Loan Facility |
$ | $ | — | |||||
Notes |
— | |||||||
First Lien Term Loan |
— | |||||||
Second Lien Term Loan |
— | |||||||
New Revolving Credit Facility |
— | |||||||
Notes payable and deferred obligations |
||||||||
|
|
|
|
|||||
Less: current portion |
||||||||
Less: debt issuance costs |
||||||||
|
|
|
|
|||||
Long-term debt, net of current portion |
$ | $ | ||||||
|
|
|
|
• | a first lien credit agreement (the “First Lien Credit Agreement”) that provided for: |
• | a $ |
• | a $ |
• | commitments for an additional $ |
• | uncommitted incremental revolving and first lien term loan facilities, subject to certain incurrence tests; and |
• | a second lien credit agreement (the “Second Lien Credit Agreement”) that provided for: |
• | a $ |
• | uncommitted incremental second lien term loan facilities, subject to certain incurrence tests. |
(in thousands) |
||||
2021 |
$ | |||
2022 |
||||
2023 |
||||
2024 |
||||
2025 |
||||
Thereafter |
||||
|
|
|||
Total future minimum principal payments |
$ | |||
|
|
(in thousands) |
Classification |
December 31, 2020 |
December 31, 2019 |
|||||||||
Assets |
||||||||||||
Operating lease right-of-use |
Other assets | $ | ||||||||||
Liabilities |
||||||||||||
Current operating lease liabilities |
Other accrued expenses | |||||||||||
Noncurrent operating lease liabilities |
Other long-term liabilities |
|||||||||||
Total leased liabilities |
$ | |||||||||||
Year Ended December 31, |
||||||||
(in thousands) |
2020 |
2019 |
||||||
Cash paid for operating lease liabilities |
$ | |||||||
Right-of-use |
||||||||
Weighted-average remaining lease term |
||||||||
Weighted-average discount rate |
% | % |
(in thousands) |
||||
2021 |
$ | |||
2022 |
||||
2023 |
||||
2024 |
||||
2025 |
||||
Thereafter |
||||
Total lease payments |
$ | |||
Less imputed interest |
( |
) | ||
Present value of lease liabilities |
$ | |||
December 31, 2020 |
||||||||||||||||
(in thousands) |
Fair Value |
Level 1 |
Level 2 |
Level 3 |
||||||||||||
Assets measured at fair value |
||||||||||||||||
Cash and cash equivalents |
$ | $ | $ | — | $ | — | ||||||||||
Derivative financial instruments |
— | — | ||||||||||||||
Total assets measured at fair value |
$ | $ | $ | $ | — | |||||||||||
Liabilities measured at fair value |
||||||||||||||||
Derivative financial instruments |
$ | $ | — | $ | $ | — | ||||||||||
Warrant liability |
— | — | ||||||||||||||
Contingent consideration liabilities |
— | — | ||||||||||||||
Total liabilities measured at fair value |
$ | $ | — | $ | $ | |||||||||||
December 31, 2019 |
||||||||||||||||
(in thousands) |
Fair Value |
Level 1 |
Level 2 |
Level 3 |
||||||||||||
Assets measured at fair value |
||||||||||||||||
Cash and cash equivalents |
$ | $ | $ | — | $ | — | ||||||||||
Contingent consideration receivable |
— | — | ||||||||||||||
Total assets measured at fair value |
$ | $ | $ | — | $ | |||||||||||
Liabilities measured at fair value |
||||||||||||||||
Derivative financial instruments |
$ | $ | — | $ | $ | — | ||||||||||
Contingent consideration liabilities |
— | — | ||||||||||||||
Total liabilities measured at fair value |
$ | $ | — | $ | $ | |||||||||||
Year Ended December 31, 2020 |
Date of Transaction October 28, 2020 |
|||||||
Fair value warrants per share |
$ | $ | ||||||
Share price |
$ | $ | ||||||
Exercise price per share |
$ | $ | ||||||
Term (years) |
||||||||
Implied volatility |
% | % | ||||||
Risk-free interest rate |
% | % | ||||||
Dividend yield |
% | % |
(in thousands) |
Carrying Value |
Fair Value (Level 2) |
||||||
Balance at December 31, 2020 |
||||||||
New Term Loan Credit Facility |
$ | $ | ||||||
Notes |
||||||||
New Revolving Credit Facility |
||||||||
Notes payable and deferred obligations |
||||||||
|
|
|
|
|||||
Total long-term debt |
$ | $ | ||||||
|
|
|
|
(in thousands) |
Carrying Value |
Fair Value (Level 2) |
||||||
Balance at December 31, 2019 |
||||||||
First Lien Term Loan |
$ | $ | ||||||
Second Lien Term Loan |
||||||||
Notes payable and deferred obligations |
||||||||
|
|
|
|
|||||
Total long-term debt |
$ | $ | ||||||
|
|
|
|
Year Ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
Grant date fair value |
$ | $ | $ | |||||||||
Dividend yield |
% | % | % | |||||||||
Expected volatility |
% | % | % | |||||||||
Risk-free interest rate |
% | % | % | |||||||||
Lack of marketability discount |
% | % | % | |||||||||
Expected term (years) |
Year Ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
Grant date fair value |
$ | $ | $ | |||||||||
Dividend yield |
% | % | % | |||||||||
Yield Test Probability |
% | % | % | |||||||||
Cost of Equity Capital |
% | % | % | |||||||||
Expected term (years) |
Year Ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
Beginning of the period |
||||||||||||
Grants |
||||||||||||
Forfeitures |
( |
) | ( |
) | ( |
) | ||||||
Repurchases |
— | — | ( |
) | ||||||||
End of the period |
||||||||||||
Year Ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
Beginning of the period |
— | |||||||||||
Grants |
||||||||||||
Forfeitures |
( |
) | ( |
) | ( |
) | ||||||
End of the period |
||||||||||||
Year Ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
Grant date fair value |
$ | $ | $ | |||||||||
Dividend yield |
% | % | % | |||||||||
Expected volatility |
% | % | % | |||||||||
Risk-free interest rate |
% | % | % | |||||||||
Lack of marketability discount |
% | % | % | |||||||||
Expected term (years) |
• | in whole and not in part; |
• | at a price of $ |
• | upon a minimum of 30 days’ prior written notice of redemption; and |
• | 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. |
• | in whole and not in part; |
• |
• | upon a minimum of 30 days’ prior written notice of redemption; |
• |
• | if, and only if, an effective registration statement covering the shares of Class A common stock issuable upon exercise of the warrants and a current prospectus relating thereto is available throughout the |
(In thousands) |
Severance |
Facilities and Other Costs |
Total Restructuring Charges |
|||||||||
Balance at December 31, 2017 |
$ | $ | — | $ | ||||||||
Charges |
||||||||||||
Payments/utilization |
( |
) | ( |
) | ( |
) | ||||||
Foreign exchange translation effects |
( |
) | ( |
) | ( |
) | ||||||
Balance at December 31, 2018 |
||||||||||||
Charges |
||||||||||||
Payments/utilization |
( |
) | ( |
) | ( |
) | ||||||
Balance at December 31, 2019 |
$ | $ | $ | |||||||||
Charges |
||||||||||||
Payments/utilization |
( |
) | ( |
) | ( |
) | ||||||
Balance at December 31, 2020 |
$ | $ | $ | |||||||||
Year Ended December 31, |
||||||||||||
(In thousands) |
2020 |
2019 |
2018 |
|||||||||
Sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
$ | $ | $ | |||||||||
Marketing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
||||||||||||
Total restructuring charges . . . . . . . . . . . . . . . . . . . . |
$ | $ | $ | |||||||||
Year Ended December 31, |
||||||||||||
(in thousands) |
2020 |
2019 |
2018 |
|||||||||
Current tax (benefit) expense |
||||||||||||
Federal |
$ | ( |
$ |
$ | ||||||||
State |
||||||||||||
Foreign |
||||||||||||
Total current tax expense |
||||||||||||
Deferred tax (benefit) expense |
||||||||||||
Federal |
( |
) | ( |
) | ( |
) | ||||||
State |
( |
) | ( |
) | ||||||||
Foreign |
( |
) | ( |
) | ( |
) | ||||||
Total deferred tax benefit |
( |
) | ( |
) | ( |
) | ||||||
Total (benefit from) provision for income taxes |
$ | ( |
) | $ | $ | ( |
) | |||||
Year Ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
Statutory U.S. rate |
% | % | % | |||||||||
State tax, net of federal tax benefit |
( |
)% | ( |
)% | % | |||||||
Foreign tax, net of federal tax benefit |
% | ( |
)% | ( |
)% | |||||||
Goodwill impairment |
— | — | ( |
)% | ||||||||
Global Intangible Low Taxed Income |
— | ( |
)% | ( |
)% | |||||||
Transaction expenses |
( |
)% | ( |
)% | ( |
)% | ||||||
Disallowed Executive Compensation |
( |
)% | — | — | ||||||||
Equity-based compensation |
( |
)% | ( |
)% | % | |||||||
Meals and entertainment |
( |
)% | ( |
)% | ( |
)% | ||||||
Contingent consideration fair value adjustment |
( |
)% | % | % | ||||||||
Fair value of warrant liability |
( |
)% | — | — | ||||||||
Non-deductible expenses |
( |
)% | ( |
)% | — | |||||||
Return to provision on permanent differences |
% | % | % | |||||||||
Work opportunity tax credit |
% | % | — | |||||||||
Research and development credit |
% | % | — | |||||||||
Other |
% | ( |
)% | ( |
)% | |||||||
Effective tax rate |
% | ( |
)% | % | ||||||||
Year Ended December 31, |
||||||||||||
(in thousands) |
2020 |
2019 |
2018 |
|||||||||
U.S. sources |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Non-U.S. sources |
||||||||||||
Loss before income taxes |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
December 31, |
||||||||
(in thousands) |
2020 |
2019 |
||||||
Deferred tax assets |
||||||||
Accrued liabilities |
$ | $ | ||||||
Social security tax deferral |
— | |||||||
Interest expense |
||||||||
Transaction expenses |
||||||||
Net operating losses |
||||||||
ROU liabilities |
||||||||
Debt Cost |
||||||||
Acquired intangibles, including goodwill |
||||||||
Insurance reserves |
||||||||
Other |
||||||||
Total deferred tax assets |
||||||||
Deferred tax liabilities |
||||||||
Acquired intangibles including goodwill |
||||||||
Restructuring expenses |
||||||||
Depreciation |
||||||||
ROU assets |
||||||||
Unrealized transactions |
— | |||||||
Other |
||||||||
Total deferred tax liabilities |
||||||||
Less: deferred income tax asset valuation allowances |
( |
) | ( |
) | ||||
Net deferred tax liabilities |
$ | $ | ||||||
December 31, |
||||||||
(in thousands) |
2020 |
2019 |
||||||
Reported as: |
||||||||
Noncurrent deferred tax asset |
$ | $ | ||||||
Noncurrent deferred tax liability |
||||||||
Net deferred tax liabilities |
$ | $ | ||||||
(in thousands) |
Sales |
Marketing |
Total |
|||||||||
Year Ended December 31, 2020 |
||||||||||||
Revenues |
$ | $ | $ | |||||||||
Depreciation and amortization |
$ | $ | $ | |||||||||
Operating income |
$ | $ | $ | |||||||||
Year Ended December 31, 2019 |
||||||||||||
Revenues |
$ | $ | $ | |||||||||
Depreciation and amortization |
$ | $ | $ | |||||||||
Operating income |
$ | $ | $ | |||||||||
Year Ended December 31, 2018 |
||||||||||||
Revenues |
$ | $ | $ | |||||||||
Depreciation and amortization |
$ | $ | $ | |||||||||
Operating loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) |
Year Ended December 31, |
||||||||||||
(in thousands) |
2020 |
2019 |
2018 |
|||||||||
Revenues |
||||||||||||
North America |
$ | $ | $ | |||||||||
International |
||||||||||||
Total revenues |
$ | $ | $ | |||||||||
December 31, |
||||||||
(in thousands) |
2020 |
2019 |
||||||
Long-Lived Assets |
||||||||
North America |
$ | $ | ||||||
International |
||||||||
Total long-lived assets |
$ | $ | ||||||
December 31, |
||||||||
(in thousands) |
2020 |
2019 |
||||||
ASSETS |
||||||||
Investment in subsidiaries |
$ | $ | ||||||
Total assets |
$ | $ | ||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
||||||||
Warrant liability |
||||||||
Total liability |
||||||||
Equity attributable to stockholders of Advantage Solutions Inc. |
||||||||
Common stock $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
Loans to Karman Topco L.P. |
( |
) | ( |
) | ||||
Accumulated other comprehensive loss |
( |
) | ||||||
Total equity attributable to stockholders of Advantage Solutions Inc. |
||||||||
Equity attributable to noncontrolling interest |
— | — | ||||||
Total stockholders’ equity |
||||||||
Total liabilities and stockholders’ equity |
||||||||
Year Ended December 31, |
||||||||||||
(in thousands) | 2020 |
2019 |
2018 |
|||||||||
Revenues |
$ | $ | $ | |||||||||
Cost of revenues |
||||||||||||
Selling, general, and administrative expenses |
||||||||||||
Depreciation and amortization |
||||||||||||
Total expenses |
||||||||||||
Operating income |
||||||||||||
Other expenses: |
||||||||||||
Change in fair value of warrant liability |
||||||||||||
Interest expense, net |
||||||||||||
Total other expenses |
||||||||||||
Loss before income taxes and equity in net income of subsidiaries |
( |
) | ||||||||||
Provision for income taxes |
||||||||||||
Net loss before equity in net income of subsidiaries |
( |
) | ||||||||||
Equity in net loss of subsidiaries |
( |
) | ( |
) | ( |
) | ||||||
Net loss attributable to subsidiaries |
( |
) | ( |
) | ( |
) | ||||||
Other comprehensive income (loss), net of tax Equity in comprehensive income (loss) of subsidiaries |
( |
) | ||||||||||
Total comprehensive loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
March 31, |
December 31, |
|||||||
(in thousands, except per share data) |
2021 |
2020 |
||||||
ASSETS |
||||||||
Current assets |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Restricted cash |
||||||||
Accounts receivable, net of allowance for expected credit losses of $ |
||||||||
Prepaid expenses and other current assets |
||||||||
Total current assets |
||||||||
Property and equipment, net |
||||||||
Goodwill |
||||||||
Other intangible assets, net |
||||||||
Investments in unconsolidated affiliates |
||||||||
Other assets |
||||||||
Total assets |
$ | $ | ||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
||||||||
Current liabilities |
||||||||
Current portion of long-term debt |
$ | $ | ||||||
Accounts payable |
||||||||
Accrued compensation and benefits |
||||||||
Other accrued expenses |
||||||||
Deferred revenue |
||||||||
Total current liabilities |
||||||||
Long-term debt, net of current portion |
||||||||
Deferred income tax liabilities, net |
||||||||
Warrant liability |
||||||||
Other long-term liabilities |
||||||||
Total liabilities |
||||||||
Commitments and contingencies (Note 10) |
||||||||
Redeemable noncontrolling interest |
— | |||||||
Equity attributable to stockholders of Advantage Solutions Inc. |
||||||||
Preferred stock, |
||||||||
Common stock, $ |
||||||||
Additional paid in capital |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
Loans to Topco |
( |
) | ( |
) | ||||
Accumulated other comprehensive (loss) income |
( |
) | ||||||
Total equity attributable to stockholders of Advantage Solutions Inc. |
||||||||
Nonredeemable noncontrolling interest |
||||||||
Total stockholders’ equity |
||||||||
Total liabilities, redeemable noncontrolling interest, and stockholders’ equity |
$ | $ | ||||||
Three Months Ended March 31, |
||||||||
(in thousands, except share and per share data) |
2021 |
2020 |
||||||
Revenues |
$ | $ | ||||||
Cost of revenues (exclusive of depreciation and amortization shown separately below) |
||||||||
Selling, general, and administrative expenses |
||||||||
Depreciation and amortization |
||||||||
Total expenses |
||||||||
Operating income |
||||||||
Other expenses: |
||||||||
Change in fair value of warrant liability |
||||||||
Interest expense, net |
||||||||
Total other expenses |
||||||||
Income (loss) before income taxes |
( |
) | ||||||
Provision for income taxes |
||||||||
Net loss |
( |
) | ( |
) | ||||
Less: net loss attributable to noncontrolling interest |
( |
) | ( |
) | ||||
Net loss attributable to stockholders of Advantage Solutions Inc. |
( |
) | ( |
) | ||||
Other comprehensive loss, net of tax: |
||||||||
Foreign currency translation adjustments |
( |
) | ( |
) | ||||
Total comprehensive loss attributable to stockholders of Advantage Solutions Inc. |
$ | ( |
) | $ | ( |
) | ||
Net loss per common share: |
||||||||
Basic and diluted |
$ | ( |
) | $ | ( |
) | ||
Weighted-average number of common shares: |
||||||||
Basic and diluted |
||||||||
(in thousands, except share data) |
Common Stock |
Additional Paid-in Capital |
Accumulated Deficit |
Loans to Topco |
Accumulated Other Comprehensive Income (Loss) |
Advantage Solutions Inc. Stockholders’ Equity |
Nonredeemable noncontrolling Interests |
Total Stockholders’ Equity |
||||||||||||||||||||||||||||
Shares |
Amount |
|||||||||||||||||||||||||||||||||||
Balance at January 1, 2021 |
$ | $ | $ | ( |
) | $ | ( |
) | $ | $ | $ | $ | ||||||||||||||||||||||||
Comprehensive loss |
||||||||||||||||||||||||||||||||||||
Net loss |
— | — | — | ( |
) | — | — | ( |
) | ( |
) | ( |
) | |||||||||||||||||||||||
Foreign currency translation adjustments |
— | — | — | — | — | ( |
) | ( |
) | ( |
) | ( |
) | |||||||||||||||||||||||
Total comprehensive loss |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Loans to Topco |
— | — | — | — | ( |
) | — | ( |
) | — | ( |
) | ||||||||||||||||||||||||
Equity-based compensation of Topco |
— | — | ( |
) | — | — | — | ( |
) | — | ( |
) | ||||||||||||||||||||||||
Vesting of stock based compensation awards |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||
Stock-based compensation expense |
— | — | — | — | — | — | ||||||||||||||||||||||||||||||
Balance at March 31, 2021 |
$ | $ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||||
(in thousands, except share data) |
Common Stock |
Additional Paid-in Capital |
Accumulated Deficit |
Loans to Topco |
Accumulated Other Comprehensive Income (Loss) |
Advantage Solutions Inc. Stockholders’ Equity |
Nonredeemable noncontrolling Interests |
Total Stockholders’ Equity |
||||||||||||||||||||||||||||
Shares |
Amount |
|||||||||||||||||||||||||||||||||||
Balance at January 1, 2020 |
$ | $ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||||
Comprehensive loss |
||||||||||||||||||||||||||||||||||||
Net loss |
— | — | — | ( |
) | — | — | ( |
) | ( |
) | ( |
) | |||||||||||||||||||||||
Foreign currency translation adjustments |
— | — | — | — | — | ( |
) | ( |
) | ( |
) | ( |
) | |||||||||||||||||||||||
Total comprehensive loss |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Balance at March 31, 2020 |
$ | $ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||||
Three Months Ended March 31, |
||||||||
(in thousands) |
2021 |
2020 |
||||||
CASH FLOWS FROM OPERATING ACTIVITIES |
||||||||
Net loss |
$ | ( |
) | $ | ( |
) | ||
Adjustments to reconcile net loss to net cash provided by operating activities |
||||||||
Noncash interest (income) expense |
( |
) | ||||||
Depreciation and amortization |
||||||||
Changes in fair value of warrant liability |
— | |||||||
Fair value adjustments related to contingent consideration |
( |
) | ||||||
Deferred income taxes |
||||||||
Equity-based compensation of Topco |
( |
) | — | |||||
Stock-based compensation |
— | |||||||
Equity in earnings of unconsolidated affiliates |
( |
) | ( |
) | ||||
Distribution received from unconsolidated affiliates |
||||||||
Loss on disposal of property and equipment |
— | |||||||
Changes in operating assets and liabilities, net of effects from purchases of businesses: |
||||||||
Accounts receivable |
( |
) | ||||||
Prepaid expense and other assets |
( |
) | ( |
) | ||||
Accounts payable |
( |
) | ( |
) | ||||
Accrued compensation and benefits |
( |
) | ( |
) | ||||
Deferred revenues |
||||||||
Other accrued expenses and other liabilities |
( |
) | ||||||
Net cash provided by operating activities |
||||||||
CASH FLOWS FROM INVESTING ACTIVITIES |
||||||||
Purchase of businesses, net of cash acquired |
( |
) | ( |
) | ||||
Purchase of property and equipment |
( |
) | ( |
) | ||||
Net cash used in investing activities |
( |
) | ( |
) | ||||
CASH FLOWS FROM FINANCING ACTIVITIES |
||||||||
Borrowings under lines of credit |
||||||||
Payments on lines of credit |
( |
) | ( |
) | ||||
Principal payments on long-term debt |
( |
) | ( |
) | ||||
Contingent consideration payments |
— | ( |
) | |||||
Holdback payments |
( |
) | — | |||||
Net cash (used in) provided by financing activities |
( |
) | ||||||
Net effect of foreign currency fluctuations on cash |
( |
) | ( |
) | ||||
Net change in cash, cash equivalents and restricted cash |
( |
) | ||||||
Cash, cash equivalents and restricted cash, beginning of period |
||||||||
Cash, cash equivalents and restricted cash, end of period |
$ | $ | ||||||
SUPPLEMENTAL CASH FLOW INFORMATION |
||||||||
Purchase of property and equipment recorded in accounts payable and accrued expenses |
$ | $ |
Three Months Ended March 31, |
||||||||
(in thousands) |
2021 |
2020 |
||||||
Sales brand-centric services |
$ | |
$ | |
||||
Sales retail-centric services |
||||||||
Total sales revenues |
||||||||
Marketing brand-centric services |
||||||||
Marketing retail-centric services |
||||||||
Total marketing revenues |
||||||||
Total revenues |
$ | $ | ||||||
(in thousands) |
||||
Consideration: |
||||
Cash |
$ | |||
Holdbacks |
||||
Fair value of contingent consideration |
||||
Total consideration |
$ | |||
Recognized amounts of identifiable assets acquired and liabilities assumed: |
||||
Assets |
||||
Accounts receivable |
$ | |||
Property and equipment |
||||
Identifiable intangible assets |
||||
Total assets |
||||
Liabilities |
||||
Total liabilities |
||||
Redeemable noncontrolling interest |
||||
Total identifiable net assets |
||||
Goodwill arising from acquisitions |
$ | |||
(in thousands) |
Amount |
Weighted Average Useful Life |
||||||
Client relationships |
$ | |||||||
Trade Names |
||||||||
Total identifiable intangible assets |
$ | |||||||
Three Months Ended March 31, |
||||||||
(in thousands, except per share data) |
2021 |
2020 |
||||||
Total revenues |
$ | $ | ||||||
Net income (loss) attributable to stockholders of Advantage Solutions Inc. |
$ | ( |
) | $ | ( |
) | ||
Basic and diluted net income (loss) per common share |
$ | ( |
) | $ | ( |
) |
(in thousands) |
Sales |
Marketing |
Total |
|||||||||
Gross carrying amount as of December 31, 2020 |
$ | $ | $ | |||||||||
Accumulated impairment charge (1) |
( |
) | — | ( |
) | |||||||
Balance at December 31, 2020 |
$ | $ | $ | |||||||||
Acquisitions |
— | |||||||||||
Measurement period adjustments |
( |
) | ( |
) | ||||||||
Balance at March 31, 2021 |
||||||||||||
(1) | During the fiscal year ended December 31, 2018, the Company recognized a non-cash goodwill impairment charge of $ |
March 31, 2021 |
||||||||||||||||||||
(in thousands) |
Weighted Average Useful Life |
Gross Carrying Value |
Accumulated Amortization |
Accumulated Impairment Charges (1) |
Net Carrying Value |
|||||||||||||||
Finite-lived intangible assets: |
||||||||||||||||||||
Client relationships |
$ | |
$ | |
$ | — | $ | |||||||||||||
Trade names |
— | |||||||||||||||||||
Developed technology |
— | |||||||||||||||||||
Covenant not to compete |
— | |||||||||||||||||||
Total finite-lived intangible assets |
— | |||||||||||||||||||
Indefinite-lived intangible assets: |
||||||||||||||||||||
Trade names |
— | |||||||||||||||||||
Total other intangible assets |
$ | $ | $ | $ | ||||||||||||||||
(1) | During the fiscal year ended December 31, 2018, the Company recognized a non-cash intangible asset impairment charge of $ |
December 31, 2020 |
||||||||||||||||||||
(in thousands) |
Weighted Average Useful Life |
Gross Carrying Value |
Accumulated Amortization |
Accumulated Impairment Charges |
Net Carrying Value |
|||||||||||||||
Finite-lived intangible assets: |
||||||||||||||||||||
Client relationships |
$ | |
$ | $ | — | $ | ||||||||||||||
Trade names |
— | |||||||||||||||||||
Developed technology |
— | |||||||||||||||||||
Covenant not to compete |
— | |||||||||||||||||||
Total finite-lived intangible assets |
— | |||||||||||||||||||
Indefinite-lived intangible assets: |
||||||||||||||||||||
Trade names |
— | |||||||||||||||||||
Total other intangible assets |
$ | $ | $ | $ | ||||||||||||||||
(in thousands) |
||||
Remainder of 2021 |
||||
2022 |
||||
2023 |
||||
2024 |
||||
2025 |
||||
Thereafter |
||||
Total amortization expense |
$ | |||
(in thousands) |
March 31, 2021 |
December 31, 2020 |
||||||
New Term Loan Facility |
$ | $ | ||||||
Notes |
||||||||
New Revolving Credit Facility |
||||||||
Notes payable and deferred obligations |
||||||||
Less: current portion |
||||||||
Less: debt issuance costs |
||||||||
Long-term debt, net of current portion |
$ | $ | ||||||
(in thousands) |
||||
Remainder of 2021 |
$ | |||
2022 |
||||
2023 |
||||
2024 |
||||
2025 |
||||
Thereafter |
||||
Total future minimum principal payments |
$ | |||
March 31, 2021 |
||||||||||||||||
(in thousands) |
Fair Value |
Level 1 |
Level 2 |
Level 3 |
||||||||||||
Assets measured at fair value |
||||||||||||||||
Cash and cash equivalents |
$ | $ | $ | — | $ | — | ||||||||||
Derivative financial instruments |
— | — | ||||||||||||||
Total assets measured at fair value |
$ | $ | $ | $ | — | |||||||||||
Liabilities measured at fair value |
||||||||||||||||
Derivative financial instruments |
$ | $ | — | $ | $ | — | ||||||||||
Warrant liability |
— | — | ||||||||||||||
Contingent consideration liabilities |
— | — | ||||||||||||||
Total liabilities measured at fair value |
$ | $ | — | $ | $ | |||||||||||
December 31, 2020 |
||||||||||||||||
(in thousands) |
Fair Value |
Level 1 |
Level 2 |
Level 3 |
||||||||||||
Assets measured at fair value |
||||||||||||||||
Cash and cash equivalents |
$ | $ | $ | — | $ | — | ||||||||||
Derivative financial instruments |
— | — | ||||||||||||||
Total assets measured at fair value |
$ | $ | $ | $ | — | |||||||||||
Liabilities measured at fair value |
||||||||||||||||
Derivative financial instruments |
$ | $ | — | $ | $ | |||||||||||
Warrant liability |
— | — | ||||||||||||||
Contingent consideration liabilities |
— | — | ||||||||||||||
Total liabilities measured at fair value |
$ | $ | — | $ | $ | |||||||||||
March 31, 2021 |
December 31, 2020 |
|||||||
Fair value warrants per share |
$ | $ | ||||||
Share Price |
$ | $ | ||||||
Exercise price per share |
$ | $ | ||||||
Term(years) |
||||||||
Implied volatility |
% | % | ||||||
Risk-free interest rate |
% | % | ||||||
Dividend yield |
% | % |
(in thousands) |
March 31, 2021 2020 |
|||||||
Beginning of the period |
$ | $ | ||||||
Fair value of acquisitions |
||||||||
Payments |
— | ( |
) | |||||
Measurement period adjustments |
( |
) | — | |||||
Changes in fair value |
( |
) | ||||||
Foreign exchange translation effects |
( |
) | ||||||
End of the period |
$ | $ | ||||||
(in thousands) |
Carrying Value |
Fair Value (Level 2) |
||||||
Balance at March 31, 2021 |
||||||||
New Term Loan Credit Facility |
$ | $ | ||||||
Notes |
||||||||
Notes payable and deferred obligations |
||||||||
Total long-term debt |
$ | $ | ||||||
(in thousands) |
Carrying Value |
Fair Value (Level 2) |
||||||
Balance at December 31, 2020 |
||||||||
New Term Loan Credit Facility |
$ | $ | ||||||
Notes |
||||||||
New Revolving Credit Facility |
||||||||
Notes payable and deferred obligations |
||||||||
Total long-term debt |
$ | $ | ||||||
(in thousands) |
Sales |
Marketing |
Total |
|||||||||
Three Months Ended March 31, 2021 |
||||||||||||
Revenues |
$ | $ | $ | |||||||||
Depreciation and amortization |
$ | $ | $ | |||||||||
Operating income |
$ | $ | $ | |||||||||
Three Months Ended March 31, 2020 |
||||||||||||
Revenues |
$ | $ | $ | |||||||||
Depreciation and amortization |
$ | $ | $ | |||||||||
Operating income |
$ | $ | $ |
(in thousands) |
2021 |
|||
Beginning Balance |
$ | |||
Fair value at acquisition |
||||
Net income attributable to redeemable noncontrolling interests |
||||
Foreign currency translation adjustment |
||||
Ending Balance |
$ | |||
Number of PSUs |
Weighted Average Grant Date Fair Value |
|||||||
Outstanding at January 1, 2021 |
$ | |||||||
Granted |
$ | |||||||
Vested |
$ | |||||||
Forfeited |
$ | |||||||
Outstanding at March 31, 2021 |
$ | |||||||
Number of RSUs |
Weighted Average Grant Date Fair Value |
|||||||
Outstanding at January 1, 2021 |
$ | |||||||
Granted |
$ | |||||||
Vested |
$ | |||||||
Forfeited |
$ | |||||||
Outstanding at March 31, 2021 |
$ | |||||||
(in thousands, except share and earnings per share data) |
March 31, 2021 |
March 31, 2020 |
||||||
Basic and diluted: |
||||||||
Net loss attributable to stockholders of Advantage Solutions Inc. |
$ | ( |
) | $ | ( |
) | ||
Weighted-average number of common shares |
||||||||
Basic and diluted net loss per common share |
$ | ( |
) | $ | ( |
) | ||
Item 13. |
Other Expenses of Issuance and Distribution. |
Amount |
||||
SEC registration fee |
$ | 68,719 | ||
Legal fees and expenses |
225,000 | |||
Accounting fees and expenses |
232,500 | |||
Miscellaneous |
30,000 | |||
|
|
|||
Total |
$ |
556,219 |
||
|
|
Item 14. |
Indemnification of Directors and Officers. |
Item 16. |
Exhibits. |
Exhibit No. |
Incorporated by Reference |
Filed Herewith |
||||||||||||||||||
Description |
Form |
File No. |
Exhibit |
Filing Date | ||||||||||||||||
10.15 |
ABL Revolving Credit Agreement, dated October 28, 2020, by and among Advantage Sales & Marketing Inc., as Borrower, Karman Intermediate Corp., Bank of America, N.A., as Administrative Agent and Collateral Agent, and the lender parties thereto. | 8-K | 001-38990 | 10.15 | November 3, 2020 | |||||||||||||||
10.16 |
First Lien Credit Agreement, dated October 28, 2020, by and among Advantage Sales & Marketing Inc., as Borrower, Karman Intermediate Corp., Bank of America, N.A., as Administrative Agent and Collateral Agent, and the lender parties thereto. | 8-K | 001-38990 | 10.16 | November 3, 2020 | |||||||||||||||
21.1 |
List of Subsidiaries | 10-K | 001-38990 | 21.1 | March 16, 2021 | |||||||||||||||
23.1 |
Consent of Shearman & Sterling LLP (included in Exhibit 5.1) | |||||||||||||||||||
23.2 |
Consent of PricewaterhouseCoopers LLP | X | ||||||||||||||||||
24.1 |
Powers of Attorney (included on signature page to initial filing of registration statement) | |||||||||||||||||||
101.INS |
Inline XBRL Instance Document—the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | X | ||||||||||||||||||
101.SCH |
Inline XBRL Taxonomy Extension Schema Document | X | ||||||||||||||||||
101.CAL |
Inline XBRL Taxonomy Extension Calculation Linkbase Document | X | ||||||||||||||||||
101.DEF |
Inline XBRL Taxonomy Extension Definition Linkbase Document | X | ||||||||||||||||||
101.LAB |
Inline XBRL Taxonomy Extension Label Linkbase Document | X | ||||||||||||||||||
101.PRE |
Inline XBRL Taxonomy Extension Presentation Linkbase Document | X | ||||||||||||||||||
104 |
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
† | Certain of the exhibits and schedules to this exhibit have been omitted in accordance with Regulation S-K Item 601(b)(2). The Registrant agrees to furnish supplementally a copy of all omitted exhibits and schedules to the SEC upon its request. |
# | Indicates management contract or compensatory plan or arrangement. |
Item 17. |
Undertakings. |
ADVANTAGE SOLUTIONS INC. |
/s/ Tanya Domier |
Name: Tanya Domier |
Title: Chief Executive Officer |
SIGNATURE |
TITLE |
DATE | ||
/s/ Tanya Domier Tanya Domier |
Chief Executive Officer (Principal Executive Officer) and Director |
May 18, 2021 | ||
/s/ Brian Stevens Brian Stevens |
Chief Financial Officer (Principal Financial Officer) and Chief Operating Officer |
May 18, 2021 | ||
/s/ Dean Kaye Dean Kaye |
Chief Financial Officer – North America (Principal Accounting Officer) |
May 18, 2021 | ||
* Ronald E. Blaylock |
Director |
May 18, 2021 | ||
* Cameron Breitner |
Director |
May 18, 2021 | ||
* Beverly F. Chase |
Director |
May 18, 2021 | ||
* Virginie Costa |
Director |
May 18, 2021 | ||
* Ryan Cotton |
Director |
May 18, 2021 | ||
* Timothy J. Flynn |
Director |
May 18, 2021 | ||
* Tiffany Han |
Director |
May 18, 2021 | ||
* James M. Kilts |
Director |
May 18, 2021 |
SIGNATURE |
TITLE |
DATE | ||
* Elizabeth Muñoz-Guzman |
Director |
May 18, 2021 | ||
* Brian K. Ratzan |
Director |
May 18, 2021 | ||
* Jonathan D. Sokoloff |
Director |
May 18, 2021 | ||
* David J. West |
Director |
May 18, 2021 |
* By: | /s/ Tanya Domier | |
Tanya Domier | ||
Attorney-in-fact |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Post-Effective Amendment No. 2 to the Registration Statement on Form S-1 of Advantage Solutions Inc. of our report dated March 16, 2021, except for the effects of the revision discussed in Note 1 to the consolidated financial statements and Note 1 to the financial statement schedule, the disclosures related to warrant liabilities as discussed in Note 1 to the consolidated financial statements, and the critical audit matter related to the accounting for and valuation of private placement warrants, as to which the date is May 17, 2021, relating to the financial statements and financial statement schedule of Advantage Solutions Inc., which appears in this Registration Statement. We also consent to the reference to us under the heading Experts in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Irvine, California
May 18, 2021